Alteration of oil traits in plants

FIELD OF THE INVENTION

[0002] The present invention is in the field of plant breeding and genetics and, in particular, relates to the alteration of oil phenotype in plants through the controlled expression of selective genes.

BACKGROUND OF THE INVENTION

[0003] Plant lipids have a variety of industrial and nutritional uses and are central to plant membrane function and climatic adaptation. These lipids represent a vast array of chemical structures, and these structures determine the physiological and industrial properties of the lipid. Many of these structures result either directly or indirectly from metabolic processes that alter the degree of unsaturation of the lipid. Different metabolic regimes in different plants produce these altered lipids, and either domestication of exotic plant species or modification of agronomically adapted species is usually required to produce economically large amounts of the desired lipid.

[0004] There are serious limitations to using mutagenesis to alter fatty acid composition. Screens will rarely uncover mutations that a) result in a dominant (“gain-of-function”) phenotype, b) are in genes that are essential for plant growth, and c) are in an enzyme that is not rate-limiting and that is encoded by more than one gene. In cases where desired phenotypes are available in mutant corn lines, their introgression into elite lines by traditional breeding techniques is slow and expensive, since the desired oil compositions are likely the result of several recessive genes.

[0005] Recent molecular and cellular biology techniques offer the potential for overcoming some of the limitations of the mutagenesis approach, including the need for extensive breeding. Some of the particularly useful technologies are seed-specific expression of foreign genes in transgenic plants [see Goldberg et al (1989) Cell 56:149-160], and the use of antisense RNA to inhibit plant target genes in a dominant and tissue-specific manner [see van der Krol et al (1988) Gene 72:45-50]. Other advances include the transfer of foreign genes into elite commercial varieties of commercial oilcrops, such as soybean [Chee et al (1989) Plant Physiol. 91:1212-1218; Christou et al (1989) Proc. Natl. Acad. Sci. U.S.A. 86:7500-7504; Hinchee et al (1988) Bio/Technology 6:915-922; EPO publication 0 301 749 A2], rapeseed [De Block et al (1989) Plant Physiol. 91:694-701], and sunflower [Everett et al(1987) Bio/Technology 5:1201-1204], and the use of genes as restriction fragment length polymorphism (RFLP) markers in a breeding program, which makes introgression of recessive traits into elite lines rapid and less expensive [Tanksley et al (1989) Bio/Technology 7:257-264]. However, application of each of these technologies requires identification and isolation of commercially-important genes.

[0006] The regulation of transcription of most eukaryotic genes is coordinated through sequence-specific binding of proteins to the promoter region located upstream of the gene. Many of these protein-binding sequences have been conserved during evolution and are found in a wide variety of organisms. One such feature is the “CCAAT” sequence element. (Edwards et al, 1998, Plant Physiol. 117:1015-1022). CCAAT boxes are a feature of gene promoters in many eukaryotes including several plant gene promoters.

[0007] HAP proteins constitute a large family of transcription factors first identified in yeast. They combine to from a heteromeric protein complex that activates transcription by binding to CCAAT boxes in eukaryotic promoters. The orthologous Hap proteins display a high degree of evolutionary conservation in their functional domains in all species studied to date (Li et al, 1991).

[0008] WO 00/28058 published on May 18, 2000 describes Hap3-type CCAAT-box binding transcriptional activator polynucleotides and polypeptides, especially, the leafy cotyledon 1 transcriptional activator (LEC1) polynucleotides and polypeptides.

[0009] WO 99/67405 describes leafy cotyledons 1 genes and their uses.

[0010] The human, murine and plant homologues of CCAAT-binding proteins have been isolated and characterized based on their sequence similarity with their yeast counterparts (Li et al, 1991). This high degree of sequence homology translates remarkably into functional interchangeability among orthologue proteins of different species (Sinha et al, 1995). Unlike yeast, multiple forms of each HAP homolog have been identified in plants (Edwards et al, 1998).

[0011] Molecular and genetic analysis revealed HAP members to be involved in the control of diverse and critical biological processes ranging from development and cell cycle regulation to metabolic control and homeostasis (Lotan et al, 1998; Lopez et al, 1996). In yeast, HAPs are involved in the transcriptional control of metabolic relevant processes such as the regulation of catabolic derepression of cyc1 and other genes involved in respiration (Becker et al., 1991).

[0012] In mammalian systems, several reports describe HAPs as direct or indirect regulators of several important genes involved in lipid biosynthesis such as fatty acid synthase (Roder et al, 1997), farnesyl diphosphate (FPP) synthase (Jackson et al, 1995; Ericsson et al, 1996), glycerol-3-phosphate acyltransferase (GPA, Jackson et al, 1997), acetyl-CoA carboxylase (ACC, Lopez et al, 1996) and 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) synthase (Jackson et al, 1995), among others.

[0013] In addition, other CCAAT-binding transcription factors have also been reported to be involved in different aspects of the control of lipid biosynthesis and adipocyte growth and differentiation in mammalian systems (see McKnight et al, 1989).

[0014] It appears that the currently available evidence to date points to a family of proteins of the CCAAT-binding transcription factors as important modulators of metabolism and lipid biosynthesis in mammalian systems. Such a determination has not been made for plant systems.

SUMMARY OF THE INVENTION

[0015] This invention concerns an isolated nucleotide fragment comprising a nucleic acid sequence selected from the group consisting of:

[0016] (a) a nucleic acid sequence encoding a fifth polypeptide having Hap2-like transcription factor activity, the fifth polypeptide having at least 70% identity based on the Clustal method of alignment when compared to a sixth polypeptide selected from the group consisting of SEQ ID NOs: 2, 4, 5, 6,10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38,40, 42, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72, 74, 76, 78, 80, 82, or 208, 210, 212, 214, or 216;

[0017] (b) a nucleic acid sequence encoding a seventh polypeptide having Hap5-like transcription factor activity, the seventh polypeptide having at least 80% identity based on the Clustal method of alignment when compared to an eighth polypeptide selected from the group consisting of SEQ ID NOs: 84, 86, 88, 90, 92, 94, 96, 98, 100, 102, 104, 106, 108, 110, 112, 114, 116, 118, 120, 122, 124, 126, 128, or 221;

[0018] (c) a nucleic acid sequence encoding a seventeenth polypeptide having Hap3/Lec1-like activity, the seventeenth polypeptide having at least 70% identity based on the Clustal method of alignment when compared to a eighteenth polypeptide selected from the group consisting of SEQ ID NOs: 130, 132, 134, or 136.

[0019] Also of interest are the complements of such nucleotide fragment as well as the use of such fragments or a part thereof in antisense inhibition or co-suppression in a transformed plant.

[0020] In a second embodiment, this invention concerns recombinant DNA constructs comprising such fragments, plants comprising such recombinant DNA constructs in their genome, seeds obtained from such plants and oil obtained from these seeds.

[0021] In a third embodiment, this invention concerns a method for altering oil phenotype in a plant which comprises: (a) transforming a plant with a recombinant DNA construct the invention, (b) growing the transformed plant under conditions suitable for expression of the recombinant DNA construct; and (c) selecting those transformed plants whose oil phenotype has been altered compared to the oil phenotype of an untransformed plant.

[0022] In a fourth embodiment, this invention concerns a method for altering oil phenotype in a plant which comprises:

[0023] (a) transforming a plant with a recombinant DNA construct comprising isolated nucleotide fragment comprising a nucleic acid sequence selected from the group consisting of:

[0024] (i) a nucleic acid sequence encoding a plant Hap3/Lec1 transcription factor having at least 60% identity based on the Clustal method of alignment when compared to a second polypeptide selected from the group consisting of even SEQ ID NOs: from 130 to 148, and SEQ ID NOs: 195 and 196;

[0025] (ii) the complement of the nucleic acid sequence of (i);

[0026] (iii) the sequence of (i) or (ii) or a part thereof which is useful in antisense inhibition or co-suppression in a transformed plant;

[0027] (iv) a nucleic acid sequence encoding a plant Lec1-related CCAAT binding transcription factor having at least 60% identity based on the Clustal method of alignment when compared to a second polypeptide selected from the group consisting of even SEQ ID NOs: from 150 to 178, and SEQ ID NOs: 197 to 202;

[0028] (v) the complement of the nucleic acid sequence of (iv);

[0029] (vi) the sequence of (iv) or (v) or a part thereof which is useful in antisense inhibition or co-suppression in a transformed plant;

[0030] wherein said nucleic acid sequence is operably linked to at least one regulatory sequence;

[0031] (b) growing the transformed plant under conditions suitable for expression of the recombinant DNA construct; and

[0032] (c) selecting those transformed plants whose oil phenotype has been altered compared to the oil phenotype of an untransformed plant.

[0033] In a fifth embodiment, this invention concerns a method for altering oil phenotype in a plant which comprises:

[0034] (a) transforming a plant with a recombinant DNA construct comprising an isolated nucleic acid fragment operably linked to at least one regulatory sequence wherein said fragment has a nucleic acid sequence encoding a polypeptide having a sequence identity of at least 60% based on the Clustal method of alignment when compared to a polypeptide selected from the group consisting of even SEQ ID NOs: from 2 to 178, and 206 to 214, and SEQ ID NOs: 179 to 202, 216 to 219, 221, and 222;

[0035] (b) growing the transformed plant under conditions suitable for expression of the recombinant DNA construct; and

[0036] (c) selecting those transformed plants whose oil phenotype has been altered compared to the oil phenotype of an untransformed plant.

[0037] In a sixth embodiment, this invention concerns method of mapping genetic variations related to altered oil phenotypes in a plant comprising:

[0038] (a) crossing two plant varieties; and

[0039] (b) evaluating genetic variations with respect to nucleic acid sequences set forth in any one of the odd SEQ ID NOs: from 1 to 177, or 207 to 215, or SEQ ID NO: 220 in progeny plants resulting from the cross of step (a) wherein the evaluation is made using a method selected from the group consisting of: RFLP analysis, SNP analysis, and PCR-based analysis.

[0040] In a seventh embodiment, this invention concerns a method of molecular breeding to obtain altered oil phenotypes in a plant comprising:

[0041] (a) crossing two plant varieties; and

[0042] (b) evaluating genetic variations with respect to nucleic acid sequences set forth in any one of the odd SEQ ID NOs: from 1 to 177, or 207 to 215, or SEQ ID NO: 220 in progeny plants resulting from the cross of step (a) wherein the evaluation is made using a method selected from the group consisting of: RFLP analysis, SNP analysis, and PCR-based analysis.

[0043] In an eighth embodiment, this invention concerns a method for altering oil phenotype in a plant which comprises:

[0044] (a) transforming a plant with a recombinant DNA construct comprising isolated nucleotide fragment comprising a nucleic acid sequence selected from the group consisting of:

[0045] (i) a nucleic acid sequence encoding a plant Hap3/Lec1 transcription factor having at least 70% identity based on the Clustal method of alignment when compared to a second polypeptide selected from the group consisting of SEQ ID NOs: 130 to 148, and SEQ ID NOs: 195, 196, and 206;

[0046] (ii) the complement of the nucleic acid sequence of (iv);

[0047] (iii) the sequence of (iv) or (v) or a part thereof which is useful in antisense inhibition or co-suppression in a transformed plant;

[0048] (b) growing the transformed plant under conditions suitable for expression of the recombinant DNA construct; and

[0049] (c) selecting those transformed plants whose oil phenotype has been altered compared to the oil phenotype of an untransformed plant.

[0050] In a ninth embodiment, this invention concerns a method to isolate nucleic acid fragments associated with altering oil phenotype in a plant which comprises:

[0051] (a) comparing even SEQ ID NOs: from 2 to 178, and 206 to 214, and SEQ ID NOs: 179 to 202, 216 to 219, 221, and 222 with other polypeptide sequences for the purpose of identifying polypeptides associated with altering oil phenotype in a plant;

[0052] (b) identifying the conserved sequences(s) or 4 or more amino acids obtained in step (a);

[0053] (c) making region-specific nucleotide probe(s) or oligomer(s) based on the conserved sequences identified in step (b); and

[0054] (d) using the nucleotide probe(s) or oligomer(s) of step (c) to isolate sequences associated with altering oil phenotype by sequence dependent protocols.

BRIEF DESCRIPTION OF THE FIGURES AND SEQUENCE LISTINGS

[0055] The invention can be more fully understood from the following detailed description and the accompanying drawings and Sequence Listing which form a part of this application.

[0056]
FIG. 1 shows the fatty acid composition of maize somatic embryos over-expressing Hap3/Lec1 (solid bars, “Hap3/Lec1”) compared to control embryos (striped bars, “con”). A ubiquitin promoter was used to drive Hap3/Lec1 expression in maize embryogenic callus. More than ten different events were analyzed by GC for fatty acid content-composition and compared to controls transformed with the selectable marker (BAR gene) plasmid alone. The somatic embryos over-expressing Lec1 contain elevated fatty acid contents averaging 119% over control oil levels.

[0057]
FIG. 2 shows the fatty acid composition of maize embryos transformed with additional copies of Hap3/Lec1 (solid bars, “+transgene”) compared to control embryos (cross-hatched bars, “−transgene”). An oleosin promoter was used to direct the expression of a transgenic copy of Hap3/Lec 1. More than twenty events producing segregating T1 seed were analyzed by NMR for embryo oil content. Six to twelve embryos were analyzed for each of five different events. Some embryos within each event contained elevated oil content. The same embryos from these five events were analyzed by PCR to determine the presence or absence of the Lec1 construct. Embryos with high oil were always found to contain the Lec1 construct (darkly shaded bars), whereas embryos with normal levels of oil were typically found not to contain the Lec1 construct (cross-hatched bars). These data demonstrate the presence of the Lec1 gene does lead to increased oil in the embryo. It is believed that embryos containing sharply higher levels of oil were homozygous for the Lec1 construct, as these events were segregating 1:2:1. The oil concentration in the embryos containing the Lec1 construct greatly surpassed any increase previously achieved through enzymatic modification of the fatty acid biosynthetic pathway, with some embryos containing an average increase of 56% in embryo oil content.

[0058] Table 1 lists the polypeptides that are described herein, the designation of the cDNA clones that comprise the nucleic acid fragments encoding polypeptides representing all or a substantial portion of these polypeptides (for the corresponding SEQ ID NO: identifier as used in the attached Sequence Listing see Table 3). The sequence descriptions and Sequence Listing attached hereto comply with the rules governing nucleotide and/or amino acid sequence disclosures in patent applications as set forth in 37 C.F.R. §1.821-1.825.

1TABLE 1Genes Involved in Alteration of Oil Traits in PlantsGene NameClonePlantHap2a transcription factorncs.pk0013.c4Catalpa [Catalpaspeciosa]Hap2c-like transcriptionetr1c.pk006.f9cattail [Typha latifolia]factorHap2a transcription factorvmb1na.pk015.d18:fisgrape [Vitis sp.]Hap2a transcription factorvpl1c.pk008.o5:fisgrape [Vitis sp.]Hap2c-like transcriptionvdb1c.pk001.m5:fisgrape [Vitis sp.]factorHap2 transcription factorcho1c.pk004.b19:fismaize [Zea mays]Hap2 transcription factorp0015.cdpgu90r:fismaize [Zea mays]Hap2a transcription factorcta1n.pk0010.f3:fismaize [Zea mays]Hap2a-like transcriptioncco1n.pk0014.d4:fismaize [Zea mays]factorHap2a-like transcriptioncco1n.pk086.d20:fismaize [Zea mays]factorHap2b transcription factorp0126.cnlau71r:fismaize [Zea mays]Hap2b-like transcriptionp0104.cabav52rmaize [Zea mays]factorHap2c transcription factorcho1c.pk007.l21:fismaize [Zea mays]Hap2c-like transcriptioncontig of:maize [Zea mays]factorcca.pk0026.d6cen3n.pk0061.e10:fiscen3n.pk0135.c2cho1c.pk001.n24p0092.chwae40rHap2c-like transcriptioncpf1c.pk006.e3:fismaize [Zea mays]factorHap2c-like transcriptioncontig of:maize [Zea mays]factorcr1n.pk0080.g6p0003.cgpge51rHap2c-like transcriptionp0015.cpdfm55r:fismaize [Zea mays]factorHap2c-like transcriptionp0083.cldct11r:fismaize [Zea mays]factorHap2c-like transcriptionp0083.cldeu68r:fismaize [Zea mays]factorHap2a transcription factorpps1c.pk001.h3:fisprickly poppy[Argemone mexicana]Hap2c-like transcriptionpps1c.pk007.j21:fisprickly poppyfactor[Argemone mexicana]Hap2 transcription factorrr1.pk0030.f7:fisrice [Oryza sativa]Hap2a transcription factorr1s72.pk0023.c8:fisrice [Oryza sativa]Hap2a-like transcriptionrca1n.pk002.c15rice [Oryza sativa]factorHap2a-like transcriptionrds3c.pk001.g9rice [Oryza sativa]factorHap2b transcription factorrca1n.pk002.j3:fisrice [Oryza sativa]Hap2c-like transcriptionrca1n.pk029.n22:fisrice [Oryza sativa]factorHap2c-like transcriptionrl0n.pk131.j17rice [Oryza sativa]factorHap2a transcription factorsdp3c.pk018.b9:fissoybean [Glycinemax]Hap2a transcription factorsfl1.pk0102.h8soybean [Glycinemax]Hap2a transcription factorsrr3c.pk001.l10:fissoybean [Glycinemax]Hap2a-like transcriptionsdp2c.pk003.o5:fissoybean [Glycinefactormax]Hap2b transcription factorsif1c.pk001.m16:fissoybean [Glycinemax]Hap2c-like transcriptionsrc1c.pk003.o16:fissoybean [Glycinefactormax]Hap2c-like transcriptionsrc3c.pk012.m6:fissoybean [Glycinefactormax]Hap2c-like transcriptionhss1c.pk011.h10:fissunflower [Helianthusfactorsp.]Hap2 transcription factorwr1.pk0094.f2:fiswheat-common[Triticum aestivum]Hap2a-like transcriptionwre1n.pk0143.h2:fiswheat-commonfactor[Triticum aestivum]Hap2b transcription factorwds1f.pk002.p21:fiswheat-common[Triticum aestivum]Hap2c transcription factorcontig of:wheat-commonwdi1c.pk002.b10[Triticum aestivum]wr1.pk0153.c7:fisHap2c-like transcriptionwre1n.pk0066.e4:fiswheat-commonfactor[Triticum aestivum]Hap2c-like transcriptionncs.pk0013.c4:fiscatalpa [Catalpafactorspeciosa]Hap2c-like transcriptionp0117.chc1n94r:fismaize [Zea mays]factorHap2c-like transcriptionrdi2c.pk011.f19:fisrice [Oryza sativa]factorHap2c-like transcriptionsfl1.pk0101.g7:fissoybean [Glycinefactormax]Hap2c-like transcriptionwdi1c.pk002.b10:fiswheat-commonfactor[Triticum aestivum]Hap5c-like transcriptionect1c.pk001.k17:fisCanna [Canna edulis]factorHap5a-like transcriptionvrr1c.pk004.o20:fisgrape [Vitis sp.]factorHap5a-like transcriptionclm1f.pk001.k17:fismaize [Zea mays]factorHap5b-like transcriptioncde1n.pk003.a5:fismaize [Zea mays]factorHap5b-like transcriptioncen3n.pk0164.a10:fismaize [Zea mays]factorHap5b-like transcriptionp0118.chsbc77rmaize [Zea mays]factorHap5c-like transcriptioncco1n.pk055.o18:fismaize [Zea mays]factorHap5c-like transcriptioncho1c.pk001.l23:fismaize [Zea mays]factorHap5c-like transcriptioncse1c.pk001.h6:fismaize [Zea mays]factorHap5a-like transcriptionrlm3n.pk005.d20:fisrice [Oryza sativa]factorHap5b-like transcriptionrr1.pk0003.a3:fisrice [Oryza sativa]factorHap5b-like transcriptionrr1.pk0039.d4:fisrice [Oryza sativa]factorHap5c-like transcriptionrca1n.pk021.b20:fisrice [Oryza sativa]factorHap5a-like transcriptionsdp2c.pk029k17:fissoybean [Glycinefactormax]Hap5a-like transcriptionsdp2c.pk044.e5:fissoybean [Glycinefactormax]Hap5b-like transcriptionsgs4c.pk004.j2soybean [Glycinefactormax]Hap5b-like transcriptionsrc3c.pk002.h4:fissoybean [Glycinefactormax]Hap5b-like transcriptionsrc3c.pk009.b15:fissoybean [Glycinefactormax]Hap5b-like transcriptionsrc3c.pk019.d4:fissoybean [Glycinefactormax]Hap5c-like transcriptionsls1c.pk032.j4:fissoybean [Glycinefactormax]Hap5 transcription factorwdk2c.pk009.e4:fiswheat-common[Triticum aestivum]Hap5a-like transcriptioncontig of:wheat-commonfactorw1m96.pk036.j11[Triticum aestivum]w1m96.pk060.d5:fisHap5c-like transcriptionwle1n.pk0076.h7:fiswheat-commonfactor[Triticum aestivum]Hap5c-like transcriptionsgs4c.pk004.j2:fissoybean [Glycinefactormax]Lec1-embryonic typeeas1c.pk003.e16amaranth[Amaranthusretroflexus]Lec1-embryonic typefds1n.pk008.m14balsam pear[Momordica charantia]Lec1-embryonic typep0015.cdpgp75rb:fismaize [Zea mays]Lec1-embryonic typep0083.clder12r:fismaize [Zea mays]Lec1-embryonic typepps1c.pk002.l19prickly poppy[Argemone mexicana]Lec1-embryonic typeContig of:soybean [Glycinescb1c.pk004.j10max]se1.pk0042.d8:fisLec1-embryonic typese2.11d12:fissoybean [Glycinemax]Lec1-embryonic typeses2w.pk0015.a4:fissoybean [Glycinemax]Lec1-embryonic typevs1n.pk013.m13:fisvernonia [Vernoniamespilifolia]Lec1-embryonic typewdk3c.pk023.h15:fiswheat-common[Triticum aestivum]Lec1-related CCAAT bindingect1c.pk007.p18:fisCanna [Canna edulis]proteinLec1-related CCAAT bindingfds.pk0003.h5:fisbalsam pearprotein[Momordica charantia]Lec1-related CCAAT bindingeef1c.pk004.c8:fiseucalyptusprotein[Eucalyptus grandis]Lec1-related CCAAT bindingcbn10.pk0005.e6:fismaize [Zea mays]proteinLec1-related CCAAT bindingp0006.cbysa51r:fismaize [Zea mays]proteinLec1-related CCAAT bindingrl0n.pk0061.c8:fisrice [Oryza sativa]proteinLec1-related CCAAT bindingrsl1n.pk002.g10:fisrice [Oryza sativa]proteinLec1-related CCAAT bindingses4d.pk0037.e3:fissoybean [Glycineproteinmax]Lec1-related CCAAT bindingsrc2c.pk003.i13:fissoybean [Glycineproteinmax]Lec1-related CCAAT bindingsrc2c.pk011.m12:fissoybean [Glycineproteinmax]Lec1-related CCAAT bindingsrc2c.pk025.b3:fissoybean [Glycineproteinmax]Lec1-related CCAAT bindingsrc3c.pk028.j21:fissoybean [Glycineproteinmax]Lec1-related CCAAT bindingwkm1c.pk0002.d7:fiswheat-commonprotein[Triticum aestivum]Lec1-related CCAAT bindingwlk8.pk0001.e10:fiswheat-commonprotein[Triticum aestivum]Lec1-related CCAAT bindingw1m96.pk037.k9:fiswheat-commonprotein[Triticum aestivum]

[0059] The Sequence Listing contains the one letter code for nucleotide sequence characters and the three letter codes for amino acids as defined in conformity with the IUPAC-IUBMB standards described in Nucleic Acids Res. 13:3021-3030 (1985) and in the Biochemical J. 219 (No. 2):345-373 (1984) which are herein incorporated by reference. The symbols and format used for nucleotide and amino acid sequence data comply with the rules set forth in 37 C.F.R. §1.822.

DETAILED DESCRIPTION OF THE INVENTION

[0060] All patents, patent applications and publications which are referred to herein are incorporated by reference in their entirety.

[0061] As used herein, an “isolated nucleic acid fragment” is a polymer of RNA or DNA that is single- or double-stranded, optionally containing synthetic, non-natural or altered nucleotide bases. An isolated nucleic acid fragment in the form of a polymer of DNA may be comprised of one or more segments of cDNA, genomic DNA or synthetic DNA. Nucleotides (usually found in their 5′-monophosphate form) are referred to by their single letter designation as follows: “A” for adenylate or deoxyadenylate (for RNA or DNA, respectively), “C” for cytidylate or deoxycytidylate, “G” for guanylate or deoxyguanylate, “U” for uridylate, “T” for deoxythymidylate, “R” for purines (A or G), “Y” for pyrimidines (C or T), “K” for g or T, “H” for A or C or T, “I” for inosine, and “N” for any nucleotide.

[0062] The terms “subfragment that is functionally equivalent” and “functionally equivalent subfragment” are used interchangeably herein. These terms refer to a portion or subsequence of an isolated nucleic acid fragment in which the ability to alter gene expression or produce a certain phenotype is retained whether or not the fragment or subfragment encodes an active enzyme. For example, the fragment or subfragment can be used in the design of recombinant DNA constructs to produce the desired phenotype in a transformed plant. Recombinant DNA constructs can be designed for use in co-suppression or antisense by linking a nucleic acid fragment or subfragment thereof, whether or not it encodes an active enzyme, in the appropriate orientation relative to a plant promoter sequence.

[0063] The terms “homology”, “homologous”, “substantially similar” and “corresponding substantially” are used interchangeably herein. They refer to nucleic acid fragments wherein changes in one or more nucleotide bases does not affect the ability of the nucleic acid fragment to mediate gene expression or produce a certain phenotype. These terms also refer to modifications of the nucleic acid fragments of the instant invention such as deletion or insertion of one or more nucleotides that do not substantially alter the functional properties of the resulting nucleic acid fragment relative to the initial, unmodified fragment. It is therefore understood, as those skilled in the art will appreciate, that the invention encompasses more than the specific exemplary sequences.

[0064] Moreover, the skilled artisan recognizes that substantially similar nucleic acid sequences encompassed by this invention are also defined by their ability to hybridize, under moderately stringent conditions (for example, 0.5×SSC, 0.1% SDS, 60° C.) with the sequences exemplified herein, or to any portion of the nucleotide sequences reported herein and which are functionally equivalent to the promoter of the invention. Stringency conditions can be adjusted to screen for moderately similar fragments, such as homologous sequences from distantly related organisms, to highly similar fragments, such as genes that duplicate functional enzymes from closely related organisms. Post-hybridization washes determine stringency conditions. One set of preferred conditions involves a series of washes starting with 6×SSC, 0.5% SDS at room temperature for 15 min, then repeated with 2×SSC, 0.5% SDS at 45° C. for 30 min, and then repeated twice with 0.2×SSC, 0.5% SDS at 50° C. for 30 min. A more preferred set of stringent conditions involves the use of higher temperatures in which the washes are identical to those above except for the temperature of the final two 30 min washes in 0.2×SSC, 0.5% SDS was increased to 60° C. Another preferred set of highly stringent conditions involves the use of two final washes in 0.1×SSC, 0.1% SDS at 65° C.

[0065] With respect to the degree of substantial similarity between the target (endogenous) mRNA and the RNA region in the construct having homology to the target mRNA, such sequences should be at least 25 nucleotides in length, preferably at least 50 nucleotides in length, more preferably at least 100 nucleotides in length, again more preferably at least 200 nucleotides in length, and most preferably at least 300 nucleotides in length; and should be at least 80% identical, preferably at least 85% identical, more preferably at least 90% identical, and most preferably at least 95% identical.

[0066] Sequence alignments and percent similarity calculations may be determined using a variety of comparison methods designed to detect homologous sequences including, but not limited to, the Megalign program of the LASARGENE bioinformatics computing suite (DNASTAR Inc., Madison, Wis.). Multiple alignment of the sequences are performed using the Clustal method of alignment (Higgins and Sharp (1989) CABIOS. 5:151-153) with the default parameters (GAP PENALTY=10, GAP LENGTH PENALTY=10). Default parameters for pairwise alignments and calculation of percent identity of protein sequences using the Clustal method are KTUPLE=1, GAP PENALTY=3, WINDOW=5 and DIAGONALS SAVED=5. For nucleic acids these parameters are KTUPLE=2, GAP PENALTY=5, WINDOW=4 and DIAGONALS SAVED=4.

[0067] A “substantial portion” of an amino acid or nucleotide sequence comprises an amino acid or a nucleotide sequence that is sufficient to afford putative identification of the protein or gene that the amino acid or nucleotide sequence comprises. Amino acid and nucleotide sequences can be evaluated either manually by one skilled in the art, or by using computer-based sequence comparison and identification tools that employ algorithms such as BLAST (Basic Local Alignment Search Tool; Altschul et al (1993) J. Mol. Biol. 215:403-410; see also www.ncbi.nlm.nih.gov/BLAST/). In general, a sequence of ten or more contiguous amino acids or thirty or more contiguous nucleotides is necessary in order to putatively identify a polypeptide or nucleic acid sequence as homologous to a known protein or gene. Moreover, with respect to nucleotide sequences, gene-specific oligonucleotide probes comprising 30 or more contiguous nucleotides may be used in sequence-dependent methods of gene identification (e.g., Southern hybridization) and isolation (e.g., in situ hybridization of bacterial colonies or bacteriophage plaques). In addition, short oligonucleotides of 12 or more nucleotides may be used as amplification primers in PCR in order to obtain a particular nucleic acid fragment comprising the primers. Accordingly, a “substantial portion” of a nucleotide sequence comprises a nucleotide sequence that will afford specific identification and/or isolation of a nucleic acid fragment comprising the sequence. The instant specification teaches amino acid and nucleotide sequences encoding polypeptides that comprise one or more particular plant proteins. The skilled artisan, having the benefit of the sequences as reported herein, may now use all or a substantial portion of the disclosed sequences for purposes known to those skilled in this art. Accordingly, the instant invention comprises the complete sequences as reported in the accompanying Sequence Listing, as well as substantial portions of those sequences as defined above.

[0068] “Codon degeneracy” refers to divergence in the genetic code permitting variation of the nucleotide sequence without effecting the amino acid sequence of an encoded polypeptide. Accordingly, the instant invention relates to any nucleic acid fragment comprising a nucleotide sequence that encodes all or a substantial portion of the amino acid sequences set forth herein. The skilled artisan is well aware of the “codon-bias” exhibited by a specific host cell in usage of nucleotide codons to specify a given amino acid. Therefore, when synthesizing a nucleic acid fragment for improved expression in a host cell, it is desirable to design the nucleic acid fragment such that its frequency of codon usage approaches the frequency of preferred codon usage of the host cell

[0069] “Synthetic nucleic acid fragments” can be assembled from oligonucleotide building blocks that are chemically synthesized using procedures known to those skilled in the art. These building blocks are ligated and annealed to form larger nucleic acid fragments which may then be enzymatically assembled to construct the entire desired nucleic acid fragment. “Chemically synthesized”, as related to a nucleic acid fragment, means that the component nucleotides were assembled in vitro. Manual chemical synthesis of nucleic acid fragments may be accomplished using well established procedures, or automated chemical synthesis can be performed using one of a number of commercially available machines. Accordingly, the nucleic acid fragments can be tailored for optimal gene expression based on optimization of the nucleotide sequence to reflect the codon bias of the host cell. The skilled artisan appreciates the likelihood of successful gene expression if codon usage is biased towards those codons favored by the host. Determination of preferred codons can be based on a survey of genes derived from the host cell where sequence information is available.

[0070] “Gene” refers to a nucleic acid fragment that expresses a specific protein, including regulatory sequences preceding (5′ non-coding sequences) and following (3′ non-coding sequences) the coding sequence. “Native gene” refers to a gene as found in nature with its own regulatory sequences. The term “recombinant DNA construct” and “recombinant DNA construct” are used interchangeably herein. A recombinant DNA construct comprises an artificial combination of nucleic acid fragments, e.g., regulatory and coding sequences that are not found together in nature. For example, a recombinant DNA construct may comprise regulatory sequences and coding sequences that are derived from different sources, or regulatory sequences and coding sequences derived from the same source, but arranged in a manner different than that found in nature. A “foreign” gene refers to a gene not normally found in the host organism, but that is introduced into the host organism by gene transfer. Foreign genes can comprise native genes inserted into a non-native organism, or recombinant DNA constructs. A “transgene” is a gene that has been introduced into the genome by a transformation procedure.

[0071] “Coding sequence” refers to a DNA sequence that codes for a specific amino acid sequence. “Regulatory sequences” refer to nucleotide sequences located upstream (5′ non-coding sequences), within, or downstream (3′ non-coding sequences) of a coding sequence, and which influence the transcription, RNA processing or stability, or translation of the associated coding sequence. Regulatory sequences may include, but are not limited to, promoters, translation leader sequences, introns, and polyadenylation recognition sequences.

[0072] “Promoter” refers to a DNA sequence capable of controlling the expression of a coding sequence or functional RNA. The promoter sequence consists of proximal and more distal upstream elements, the latter elements often referred to as enhancers. Accordingly, an “enhancer” is a DNA sequence which can stimulate promoter activity and may be an innate element of the promoter or a heterologous element inserted to enhance the level or tissue-specificity of a promoter. Promoters may be derived in their entirety from a native gene, or be composed of different elements derived from different promoters found in nature, or even comprise synthetic DNA segments. It is understood by those skilled in the art that different promoters may direct the expression of a gene in different tissues or cell types, or at different stages of development, or in response to different environmental conditions. Promoters which cause a gene to be expressed in most cell types at most times are commonly referred to as “constitutive promoters”. New promoters of various types useful in plant cells are constantly being discovered; numerous examples may be found in the compilation by Okamuro and Goldberg, (1989) Biochemistry of Plants 15:1-82. It is further recognized that since in most cases the exact boundaries of regulatory sequences have not been completely defined, DNA fragments of some variation may have identical promoter activity.

[0073] An “intron” is an intervening sequence in a gene that does not encode a portion of the protein sequence. Thus, such sequences are transcribed into RNA but are then excised and are not translated. The term is also used for the excised RNA sequences. An “exon” is a portion of the sequence of a gene that is transcribed and is found in the mature messenger RNA derived from the gene, but is not necessarily a part of the sequence that encodes the final gene product.

[0074] The “translation leader sequence” refers to a DNA sequence located between the promoter sequence of a gene and the coding sequence. The translation leader sequence is present in the fully processed mRNA upstream of the translation start sequence. The translation leader sequence may affect processing of the primary transcript to mRNA, mRNA stability or translation efficiency. Examples of translation leader sequences have been described (Turner, R. and Foster, G. D. (1995) Molecular Biotechnology 3:225).

[0075] The “3′ non-coding sequences” refer to DNA sequences located downstream of a coding sequence and include polyadenylation recognition sequences and other sequences encoding regulatory signals capable of affecting mRNA processing or gene expression. The polyadenylation signal is usually characterized by affecting the addition of polyadenylic acid tracts to the 3′ end of the mRNA precursor. The use of different 3′ non-coding sequences is exemplified by Ingelbrecht et al, (1989) Plant Cell 1:671-680.

[0076] “RNA transcript” refers to the product resulting from RNA polymerase-catalyzed transcription of a DNA sequence. When the RNA transcript is a perfect complementary copy of the DNA sequence, it is referred to as the primary transcript or it may be a RNA sequence derived from post-transcriptional processing of the primary transcript and is referred to as the mature RNA. “Messenger RNA (mRNA)” refers to the RNA that is without introns and that can be translated into protein by the cell. “cDNA” refers to a DNA that is complementary to and synthesized from a mRNA template using the enzyme reverse transcriptase. The cDNA can be single-stranded or converted into the double-stranded form using the Klenow fragment of DNA polymerase I. “Sense” RNA refers to RNA transcript that includes the mRNA and can be translated into protein within a cell or in vitro. “Antisense RNA” refers to an RNA transcript that is complementary to all or part of a target primary transcript or mRNA and that blocks the expression of a target gene (U.S. Pat. No. 5,107,065). The complementarity of an antisense RNA may be with any part of the specific gene transcript, i.e., at the 5′ non-coding sequence, 3′ non-coding sequence, introns, or the coding sequence. “Functional RNA” refers to antisense RNA, ribozyme RNA, or other RNA that may not be translated but yet has an effect on cellular processes. The terms “complement” and “reverse complement” are used interchangeably herein with respect to mRNA transcripts, and are meant to define the antisense RNA of the message.

[0077] The term “endogenous RNA” refers to any RNA which is encoded by any nucleic acid sequence present in the genome of the host prior to transformation with the recombinant construct of the present invention, whether naturally-occurring or non-naturally occurring, i.e., introduced by recombinant means, mutagenesis, etc.

[0078] The term “non-naturally occurring” means artificial, not consistent with what is normally found in nature.

[0079] The term “operably linked” refers to the association of nucleic acid sequences on a single nucleic acid fragment so that the function of one is regulated by the other. For example, a promoter is operably linked with a coding sequence when it is capable of regulating the expression of that coding sequence (i.e., that the coding sequence is under the transcriptional control of the promoter). Coding sequences can be operably linked to regulatory sequences in a sense or antisense orientation. In another example, the complementary RNA regions of the invention can be operably linked, either directly or indirectly, 5′ to the target mRNA, or 3′ to the target mRNA, or within the target mRNA, or a first complementary region is 5′ and its complement is 3′ to the target mRNA.

[0080] The term “expression”, as used herein, refers to the production of a functional end-product. Expression of a gene involves transcription of the gene and translation of the mRNA into a precursor or mature protein. “Antisense inhibition” refers to the production of antisense RNA transcripts capable of suppressing the expression of the target protein. “Co-suppression” refers to the production of sense RNA transcripts capable of suppressing the expression of identical or substantially similar foreign or endogenous genes (U.S. Pat. No. 5,231,020).

[0081] “Mature” protein refers to a post-translationally processed polypeptide; i.e., one from which any pre- or propeptides present in the primary translation product have been removed. “Precursor” protein refers to the primary product of translation of mRNA; i.e., with pre- and propeptides still present. Pre- and propeptides may be but are not limited to intracellular localization signals.

[0082] “Stable transformation” refers to the transfer of a nucleic acid fragment into a genome of a host organism, including both nuclear and organellar genomes, resulting in genetically stable inheritance. In contrast, “transient transformation” refers to the transfer of a nucleic acid fragment into the nucleus, or DNA-containing organelle, of a host organism resulting in gene expression without integration or stable inheritance. Host organisms containing the transformed nucleic acid fragments are referred to as “transgenic” organisms. The preferred method of cell transformation of rice, corn and other monocots is the use of particle-accelerated or “gene gun” transformation technology (Klein et al, (1987) Nature (London) 327:70-73; U.S. Pat. No. 4,945,050), or an Agrobacterium-mediated method using an appropriate Ti plasmid containing the transgene (Ishida Y. et al, 1996, Nature Biotech. 14:745-750). The term “transformation” as used herein refers to both stable transformation and transient transformation.

[0083] Standard recombinant DNA and molecular cloning techniques used herein are well known in the art and are described more fully in Sambrook, J., Fritsch, E. F. and Maniatis, T. Molecular Cloning: A Laboratory Manual; Cold Spring Harbor Laboratory Press: Cold Spring Harbor, 1989 (hereinafter “Sambrook”).

[0084] The term “recombinant” means, for example, that a nucleic acid sequence is made by an artificial combination of two otherwise separated segments of sequence, e.g., by chemical synthesis or by the manipulation of isolated nucleic acids by genetic engineering techniques. A “recombinant DNA construct” comprises an isolated polynucleotide operably linked to at least one regulatory sequence. The term also embraces an isolated polynucleotide comprising a region encoding all or part of a functional RNA and at least one of the naturally occurring regulatory sequences directing expression in the source (e.g., organism) from which the polynucleotide was isolated, such as, but not limited to, an isolated polynucleotide comprising a nucleotide sequence encoding a herbicide resistant target gene and the corresponding promoter and 3′ end sequences directing expression in the source from which sequences were isolated.

[0085] A “transgene” is a recombinant DNA construct that has been introduced into the genome by a transformation procedure.

[0086] As used herein, “contig” refers to a nucleotide sequence that is assembled from two or more constituent nucleotide sequences that share common or overlapping regions of sequence homology. For example, the nucleotide sequences of two or more nucleic acid fragments can be compared and aligned in order to identify common or overlapping sequences. Where common or overlapping sequences exist between two or more nucleic acid fragments, the sequences (and thus their corresponding nucleic acid fragments) can be assembled into a single contiguous nucleotide sequence.

[0087] “PCR” or “Polymerase Chain Reaction” is a technique for the synthesis of large quantities of specific DNA segments, consists of a series of repetitive cycles (Perkin Elmer Cetus Instruments, Norwalk, Conn.). Typically, the double stranded DNA is heat denatured, the two primers complementary to the 3′ boundaries of the target segment are annealed at low temperature and then extended at an intermediate temperature. One set of these three consecutive steps is referred to as a cycle.

[0088] The terms “recombinant construct”, “expression construct”, “recombinant expression construct”, “recombinant DNA construct” and “recombinant DNA construct” are used interchangeably herein. Such construct may be itself or may be used in conjunction with a vector. If a vector is used then the choice of vector is dependent upon the method that will be used to transform host plants as is well known to those skilled in the art. For example, a plasmid vector can be used. The skilled artisan is well aware of the genetic elements that must be present on the vector in order to successfully transform, select and propagate host cells comprising any of the isolated nucleic acid fragments of the invention. The skilled artisan will also recognize that different independent transformation events will result in different levels and patterns of expression (Jones et al, (1985) EMBO J. 4:2411-2418; De Almeida et al, (1989) Mol. Gen. Genetics 218:78-86), and thus that multiple events must be screened in order to obtain lines displaying the desired expression level and pattern. Such screening may be accomplished by Southern analysis of DNA, Northern analysis of mRNA expression, Western analysis of protein expression, or phenotypic analysis.

[0089] Co-suppression constructs in plants previously have been designed by focusing on overexpression of a nucleic acid sequence having homology to an endogenous mRNA, in the sense orientation, which results in the reduction of all RNA having homology to the overexpressed sequence (see Vaucheret et al (1998) Plant J 16:651-659; and Gura (2000) Nature 404:804-808). The overall efficiency of this phenomenon is low, and the extent of the RNA reduction is widely variable. Recent work has described the use of “hairpin” structures that incorporate all, or part, of an mRNA encoding sequence in a complementary orientation that results in a potential “stem-loop” structure for the expressed RNA (PCT Publication WO 99/53050 published on Oct. 21, 1999). This increases the frequency of co-suppression in the recovered transgenic plants. Another variation describes the use of plant viral sequences to direct the suppression, or “silencing”, of proximal mRNA encoding sequences (PCT Publication WO 98/36083 published on Aug. 20, 1998). Both of these co-suppressing phenomena have not been elucidated mechanistically, although recent genetic evidence has begun to unravel this complex situation (Elmayan et al (1998) Plant Cell 10:1747-1757).

[0090] Alternatively, a recombinant DNA construct designed to express antisense RNA for all or part of the instant nucleic acid fragment can be constructed by linking the gene or gene fragment in reverse orientation to plant promoter sequences. Either the co-suppression or antisense recombinant DNA constructs could be introduced into plants via transformation wherein expression of the corresponding endogenous genes are reduced or eliminated.

[0091] Molecular genetic solutions to the generation of plants with altered gene expression have a decided advantage over more traditional plant breeding approaches. Changes in plant phenotypes can be produced by specifically inhibiting expression of one or more genes by antisense inhibition or cosuppression (U.S. Pat. Nos. 5,190,931, 5,107,065 and 5,283,323). An antisense or cosuppression construct would act as a dominant negative regulator of gene activity. While conventional mutations can yield negative regulation of gene activity these effects are most likely recessive. The dominant negative regulation available with a transgenic approach may be advantageous from a breeding perspective. In addition, the ability to restrict the expression of a specific phenotype to the reproductive tissues of the plant by the use of tissue specific promoters may confer agronomic advantages relative to conventional mutations which may have an effect in all tissues in which a mutant gene is ordinarily expressed.

[0092] The person skilled in the art will know that special considerations are associated with the use of antisense or cosuppression technologies in order to reduce expression of particular genes. For example, the proper level of expression of sense or antisense genes may require the use of different recombinant DNA constructs utilizing different regulatory elements known to the skilled artisan. Once transgenic plants are obtained by one of the methods described above, it will be necessary to screen individual transgenics for those that most effectively display the desired phenotype. Accordingly, the skilled artisan will develop methods for screening large numbers of transformants. The nature of these screens will generally be chosen on practical grounds. For example, one can screen by looking for changes in gene expression by using antibodies specific for the protein encoded by the gene being suppressed, or one could establish assays that specifically measure enzyme activity. A preferred method will be one which allows large numbers of samples to be processed rapidly, since it will be expected that a large number of transformants will be negative for the desired phenotype.

[0093] Loss of function mutant phenotypes may be identified for the instant cDNA clones either by targeted gene disruption protocols or by identifying specific mutants for these genes contained in a maize population carrying mutations in all possible genes (Ballinger and Benzer (1989) Proc. Natl. Acad. Sci USA 86:9402-9406; Koes et al (1995) Proc. Natl. Acad. Sci USA 92:8149-8153; Bensen et al (1995) Plant Cell 7:75-84). The latter approach may be accomplished in two ways. First, short segments of the instant nucleic acid fragments may be used in polymerase chain reaction protocols in conjunction with a mutation tag sequence primer on DNAs prepared from a population of plants in which Mutator transposons or some other mutation-causing DNA element has been introduced (see Bensen, supra). The amplification of a specific DNA fragment with these primers indicates the insertion of the mutation tag element in or near the plant gene encoding the instant polypeptides. Alternatively, the instant nucleic acid fragment may be used as a hybridization probe against PCR amplification products generated from the mutation population using the mutation tag sequence primer in conjunction with an arbitrary genomic site primer, such as that for a restriction enzyme site-anchored synthetic adaptor. With either method, a plant containing a mutation in the endogenous gene encoding the instant polypeptides can be identified and obtained. This mutant plant can then be used to determine or confirm the natural function of the instant polypeptides disclosed herein.

[0094] The terms Hap3, Lec1, and Hap3/Lec1 are used interchangeably herein and refer to a class of transcription factors. The Hap3/Lec1 class is part of a broader family that includes other transcription factors such as Hap5, Hap2, and Lec1-CCAAT. The terms Hap3-like, Lec1-like, Hap3/Lec1-like, Hap5-like, Hap2-like, Lec1-CCAAT-like, etc. refer to any transcription factors that share sequence identity as disclosed herein and/or functionality with the nucleotide sequences and the corresponding amino acid sequences encoded by such nucleotide sequences disclosed in the present invention.

[0095] Surprisingly and unexpectedly, it has been found that there are a variety of regulatory/structural nucleic acid fragments, which heretofore have not been associated with altering oil phenotype in plants, that appear to be useful in altering oil phenotype in plants. In addition to the CCAAT-binding transcription factors, other proteins which heretofore have not been associated with altering oil phenotype in plants, have been identified. The nucleic acids identified encode a diverse class of regulatory and structural polypeptides whose expression correlates with altered oil phenotypes in plants. Altering the expression of these polypeptides would be expected to have an effect in altering oil accumulation in plants.

[0096] Other protein classes identified herein include:

[0097] a Hap2 transcription factor;

[0098] a Hap5 transcription factor;

[0099] a Hap3/Lec1 or Lec1-CCAAT binding transcription factor.

[0100] They can be characterized as an isolated nucleotide fragment comprising a nucleic acid sequence selected from the group consisting of:

[0101] (a) a nucleic acid sequence encoding a fifth polypeptide having Hap2-like transcription factor activity, the fifth polypeptide having at least 70% identity based on the Clustal method of alignment when compared to a sixth polypeptide selected from the group consisting of SEQ ID NOs: 2, 4, 5, 6, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72, 74, 76, 78, 80, 82, or 208, 210, 212, 214, or 216; or

[0102] (b) a nucleic acid sequence encoding a seventh polypeptide having Hap5-like transcription factor activity, the seventh polypeptide having at least 80% identity based on the Clustal method of alignment when compared to an eighth polypeptide selected from the group consisting of SEQ ID NOs: 84, 86, 88, 90, 92, 94, 96, 98, 100, 102, 104, 106, 108, 110, 112, 114, 116, 118, 120, 122, 124, 126, 128, or 221; or

[0103] (c) a nucleic acid sequence encoding a seventeenth polypeptide having Hap3/Lec1-like activity, the seventeenth polypeptide having at least 70% identity based on the Clustal method of alignment when compared to a eighteenth polypeptide selected from the group consisting of SEQ ID NOs: 130, 132, 134, or 136.

[0104] It is understood by one skilled in the art that other percent identity ranges may be useful in the above mentioned characterization. Useful percent identities would include, but not be limited to, 45%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% and all integer percentages from 45 to 100%.

[0105] The complement of the nucleotide fragments of this inventions are encompassed within the scope of this invention.

[0106] Those skilled in the art with also appreciate that the nucleotide fragment of this invention and/or the complement thereof can be used in whole or in part in antisense inhibition or co-suppression of a transformed plant.

[0107] In a more preferred embodiment, the first polypeptide mentioned above is as follows with respect to each part, the first polypeptide in

[0108] part (a) is a Hap2 transcription factor;

[0109] part (b) is a Hap5 transcription factor;

[0110] part (c) is a Hap3/Lec1 or Lec1-CCAAT binding transcription factor

[0111] Lec1 homologs may be further identified by using conserved sequence motifs. The following amino acid sequence (given in single letter code, with “x” representing any amino acid). Under lined amino acids are those that are conserved in Lec1 but not found in Lec1-related proteins.

[0112] REQDxxMPxANVxRIMRxxLPxxAKISDDAKExIQECVSExISFxTxEANxRCxxxx RKTxxxE

[0113] In a further embodiment, this invention encompasses recombinant DNA construct comprising any of the isolated nucleic acid fragments of the invention or complement thereof operably linked to at least one regulatory sequence. It is also understood that recombinant DNA constructs comprising such fragments or complements thereof or parts of either can be used in antisense inhibition or suppression of a transformed plant.

[0114] Also within the scope of this invention is a plant comprising in its genome a recombinant DNA construct as described herein. Recombinant DNA constructs designed for plant expression such as those described herein can be introduced into a plant cell in a number of art-recognized ways. Those skilled in the art will appreciate that the choice of method might depend on the type of plant (i.e, monocot or dicot) and/or organelle (i.e., nucleus, chloroplast, mitochondria) targeted for transformation. Suitable methods for transforming plant cells include microinjection, electroporation, Agrobacterium mediated transformation, direct gene transfer and particle-accelerated or “gene gun” transformation technology as is discussed above.

[0115] Examples of plants which can be transformed include, but are not limited to, corn, soybean, wheat, rice, canola, Brassica, sorghum, sunflower, and coconut.

[0116] The regeneration, development and cultivation of plants from single plant protoplast transformants or from various transformed explants is well known in the art (Weissbach and Weissbach, In, Methods for Plant Molecular Biology, (Eds.), Academic Press, Inc., San Diego, Calif. (1988)). This regeneration and growth process typically includes the steps of selection of transformed cells, culturing those individualized cells through the usual stages of embryonic development through the rooted plantlet stage. Transgenic embryos and seeds are similarly regenerated. The resulting transgenic rooted shoots are thereafter planted in an appropriate plant growth medium such as soil.

[0117] The development or regeneration of plants containing the foreign, exogenous gene that encodes a protein of interest is well known in the art. Preferably, the regenerated plants are self-pollinated to provide homozygous transgenic plants. Otherwise, pollen obtained from the regenerated plants is crossed to seed-grown plants of agronomically important lines. Conversely, pollen from plants of these important lines is used to pollinate regenerated plants. A transgenic plant of the present invention containing a desired polypeptide is cultivated using methods well known to one skilled in the art.

[0118] There are a variety of methods for the regeneration of plants from plant tissue. The particular method of regeneration will depend on the starting plant tissue and the particular plant species to be regenerated. Methods for transforming dicots, primarily by use of Agrobacterium tumefaciens, and obtaining transgenic plants have been published for cotton (U.S. Pat. Nos. 5,004,863, 5,159,135, 5,518,908); soybean (U.S. Pat. Nos. 5,569,834 5,416,011, McCabe et. al., BiolTechnology 6:923 (1988), Christou et al., Plant Physiol. 87:671-674 (1988)); Brassica (U.S. Pat. No. 5,463,174); peanut (Cheng et al., Plant Cell Rep. 15:653-657 (1996), McKently et al., Plant Cell Rep. 14:699-703 (1995)); papaya; and pea (Grant et al., Plant Cell Rep. 15:254-258, (1995)).

[0119] Transformation of monocotyledons using electroporation, particle bombardment, and Agrobacterium have also been reported. Transformation and plant regeneration have been achieved in asparagus (Bytebier et al., Proc. Natl. Acad. Sci. (USA) 84:5354, (1987)); barley (Wan and Lemaux, Plant Physiol 104:37 (1994)); Zea mays (Rhodes et al., Science 240:204 (1988), Gordon-Kamm et al., Plant Cell 2:603-618 (1990), Fromm et al., BiolTechnology 8:833 (1990), Koziel et al., BiolTechnology 11: 194, (1993), Armstrong et al., Crop Science 35:550-557 (1995)); oat (Somers et al., BiolTechnology 10: 15 89 (1992)); orchard grass (Horn et al., Plant Cell Rep. 7:469 (1988)); rice (Toriyama et al., TheorAppl. Genet. 205:34, (1986); Part et al., Plant Mol. Biol. 32:1135-1148, (1996); Abedinia et al., Aust. J. Plant Physiol. 24:133-141 (1997); Zhang and Wu, Theor. Appl. Genet. 76:835 (1988); Zhang et al. Plant Cell Rep. 7:379, (1988); Battraw and Hall, Plant Sci. 86:191-202 (1992); Christou et al., Bio/Technology9:957 (1991)); rye (De la Pena et al., Nature 325:274 (1987)); sugarcane (Bower and Birch, Plant J. 2:409 (1992)); tall fescue (Wang et al., BiolTechnology 10:691 (1992)), and wheat (Vasil et al., Bio/Technology 10:667 (1992); U.S. Pat. No. 5,631,152).

[0120] Assays for gene expression based on the transient expression of cloned nucleic acid constructs have been developed by introducing the nucleic acid molecules into plant cells by polyethylene glycol treatment, electroporation, or particle bombardment (Marcotte et al., Nature 335:454-457 (1988); Marcotte et al., Plant Cell 1:523-532 (1989); McCarty et al., Cell 66:895-905 (1991); Hattori et al., Genes Dev. 6:609-618 (1992); Goff et al., EMBO J. 9:2517-2522 (1990)).

[0121] Transient expression systems may be used to functionally dissect gene constructs (see generally, Maliga et al., Methods in Plant Molecular Biology, Cold Spring Harbor Press (1995)). It is understood that any of the nucleic acid molecules of the present invention can be introduced into a plant cell in a permanent or transient manner in combination with other genetic elements such as vectors, promoters, enhancers etc.

[0122] In addition to the above discussed procedures, practitioners are familiar with the standard resource materials which describe specific conditions and procedures for the construction, manipulation and isolation of macromolecules (e.g., DNA molecules, plasmids, etc.), generation of recombinant organisms and the screening and isolating of clones, (see for example, Sambrook et al., Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Press (1989); Maliga et al., Methods in Plant Molecular Biology, Cold Spring Harbor Press (1995); Birren et al., Genome Analysis: Detecting Genes, 1, Cold Spring Harbor, N.Y. (1998); Birren et al., Genome Analysis: Analyzing DNA, 2, Cold Spring Harbor, N.Y. (1998); Plant Molecular Biology: A Laboratory Manual, eds. Clark, Springer, N.Y. (1997)).

[0123] Seeds obtained from such plants and oil obtained from these seeds constitute another aspect of the present invention.

[0124] In an even further aspect, the invention concerns a method for altering oil phenotype in a plant which comprises:

[0125] (a) transforming a plant with a recombinant DNA construct of the invention;

[0126] (b) growing the transformed plant under conditions suitable for expression of the recombinant DNA construct; and

[0127] (c) selecting those transformed plants whose oil phenotype has been altered compared to the oil phenotype of an untransformed plant.

[0128] In a more specific embodiment, the invention concerns a method for altering oil phenotype in a plant which comprises:

[0129] (a) transforming a plant with a recombinant DNA construct comprising isolated nucleotide fragment comprising a nucleic acid sequence selected from the group consisting of:

[0130] (i) a nucleic acid sequence encoding a plant Hap3/Lec1 transcription factor having at least 60% identity based on the Clustal method of alignment when compared to a second polypeptide selected from the group consisting of even SEQ ID NOs: from 130 to 148, and SEQ ID NOs: 195 and 196;

[0131] (ii) the complement of the nucleic acid sequence of (i);

[0132] (iii) the sequence of (i) or (ii) or a part thereof which is useful in antisense inhibition or co-suppression in a transformed plant;

[0133] (iv) a nucleic acid sequence encoding a plant Lec -related CCAAT binding transcription factor having at least 60% identity based on the Clustal method of alignment when compared to a second polypeptide selected from the group consisting of even SEQ ID NOs: from 150 to 178, and SEQ ID NOs: 197 to 202;

[0134] (v) the complement of the nucleic acid sequence of (vii);

[0135] (vi) the sequence of (iv) or (v) or a part thereof which is useful in antisense inhibition or co-suppression in a transformed plant;

[0136] wherein said nucleic acid sequence is operably linked to at least one regulatory sequence;

[0137] (b) growing the transformed plant under conditions suitable for expression of the recombinant DNA construct; and

[0138] (c) selecting those transformed plants whose oil phenotype has been altered compared to the oil phenotype of an untransformed plant.

[0139] It is understood by one skilled in the art that other percent identity ranges may be useful in the above mentioned method. Useful percent identities would include, but not be limited to, 45%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% and all integer percentages from 45 to 100%.

[0140] In an even further aspect, this invention concerns a method to isolate nucleic acid fragments associated with altering oil phenotype in a plant which comprises:

[0141] (a) comparing even SEQ ID NOs: from 2 to 178, and 206 to 214, and SEQ ID NOs: 179 to 202, 216 to 219, 221, and 222 with other polypeptide sequences fort he purpose of identifying polypeptides associated with altering oil phenotype in a plant;

[0142] (b) identifying the conserved sequences(s) or 4 or more amino acids obtained in step (a);

[0143] (c) making region-specific nucleotide probe(s) or oligomer(s) based on the conserved sequences identified in step (b); and

[0144] (d) using the nucleotide probe(s) or oligomer(s) of step (c) to isolate sequences associated with altering oil phenotype by sequence dependent protocols.

[0145] In a most preferred aspect, this invention concerns a method for altering oil phenotype in a plant which comprises:

[0146] (a) transforming a plant with a recombinant DNA construct comprising an isolated nucleic acid fragment operably linked to at least one regulatory sequence wherein said fragment has a nucleic acid sequence encoding a polypeptide having a sequence identity of at least 60% based on the Clustal method of alignment when compared to a polypeptide selected from the group consisting of even;

[0147] (b) growing the transformed plant under conditions suitable for expression of the recombinant DNA construct; and

[0148] (c) selecting those transformed plants whose oil phenotype has been altered compared to the oil phenotype of an untransformed plant.

[0149] It is understood by one skilled in the art that other percent identity ranges may be useful in the above mentioned method. Useful percent identities would include, but not be limited to, 45%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% and all integer percentages from 45 to 100%.

[0150] In another aspect, this invention also concerns a method of mapping genetic variations related to altered oil phenotypes in a plant comprising:

[0151] (a) crossing two plant varieties; and

[0152] (b) evaluating genetic variations with respect to nucleic acid sequences set forth in any one of the odd SEQ ID NOs: from 1 to 177, or 207 to 215, or SEQ ID NO: 220 in progeny plants resulting from the cross of step (a) wherein the evaluation is made using a method selected from the group consisting of: RFLP analysis, SNP analysis, and PCR-based analysis.

[0153] In another embodiment, this invention concerns a method of molecular breeding to obtain altered oil phenotypes in a plant comprising:

[0154] (a) crossing two plant varieties; and

[0155] (b) evaluating genetic variations with respect to nucleic acid sequences set forth in any one of the odd SEQ ID NOs: from 1 to 177, or 207 to 215, or SEQ ID NO: 220 in progeny plants resulting from the cross of step (a) wherein the evaluation is made using a method selected from the group consisting of: RFLP analysis, SNP analysis, and PCR-based analysis.

[0156] The genetic variability at a particular locus (gene) due to even minor base changes can alter the pattern of restriction enzyme digestion fragments that can be generated. Pathogenic alterations to the genotype can be due to deletions or insertions within the gene being analyzed or even single nucleotide substitutions that can create or delete a restriction enzyme recognition site. RFLP analysis takes advantage of this and utilizes Southern blotting with a probe corresponding to the gene of interest.

[0157] Thus, if a polymorphism (i.e., a commonly occurring variation in a gene or segment of DNA; also, the existence of several forms of a gene (alleles) in the same species) creates or destroys a restriction endonuclease cleavage site, or if it results in the loss or insertion of DNA (e.g., a variable nucleotide tandem repeat (VNTR) polymorphism), it will alter the size or profile of the DNA fragments that are generated by digestion with that restriction endonuclease. As such, individuals that possess a variant sequence can be distinguished from those having the original sequence by restriction fragment analysis. Polymorphisms that can be identified in this manner are termed “restriction fragment length polymorphisms: (“RFLPs”). RFLPs have been widely used in human and plant genetic analyses (Glassberg, UK Patent Application 2135774; Skolnick et al, Cytogen. Cell Genet. 32:58-67 (1982); Botstein et al, Ann. J. Hum. Genet. 32:314-331 (1980); Fischer et al (PCT Application WO 90/13668; Uhlen, PCT Appliction WO 90/11369).

[0158] A central attribute of “single nucleotide polymorphisms” or “SNPs” is that the site of the polymorphism is at a single nucleotide. SNPs have certain reported advantages over RFLPs or VNTRs. First, SNPs are more stable than other classes of polymorphisms. Their spontaneous mutation rate is approximately 10−9 (Kornberg, DNA Replication, W. H. Freeman & Co., San Francisco, 1980), approximately, 1,000 times less frequent than VNTRs (U.S. Pat. No. 5,679,524). Second, SNPs occur at greater frequency, and with greater uniformity than RFLPs and VNTRs. As SNPs result from sequence variation, new polymorphisms can be identified by sequencing random genomic or cDNA molecules. SNPs can also result from deletions, point mutations and insertions. Any single base alteration, whatever the cause, can be a SNP. The greater frequency of SNPs means that they can be more readily identified than the other classes of polymorphisms.

[0159] SNPs can be characterized using any of a variety of methods. Such methods include the direct or indirect sequencing of the site, the use of restriction enzymes where the respective alleles of the site create or destroy a restriction site, the use of allele-specific hybridization probes, the use of antibodies that are specific for the proteins encoded by the different alleles of the polymorphism or by other biochemical interpretation. SNPs can be sequenced by a number of methods. Two basic methods may be sued for DNA sequencing, the chain termination method of Sanger et al, Proc. Natl. Acad. Sci. (U.S.A.) 74:5463-5467 (1977), and the chemical degradation method of Maxam and Gilbert, Proc. Natl.,Acad. Sci. (U.S.A.) 74: 560-564 (1977).

[0160] Polymerase chain reaction (“PCR”) is a powerful technique used to amplify DNA millions of fold, by repeated replication of a template, in a short period of time. (Mullis et al, Cold Spring Harbor Symp. Quant. Biol. 51:263-273 (1986); Erlich et al, European Patent Application 50,424; European Patent Application 84,796; European Patent Application 258,017, European Patent Application 237,362; Mullis, European Patent Application 201,184, Mullis et al U.S. Pat. No. 4,683,202; Erlich, U.S. Pat. No. 4,582,788; and Saiki et al, U.S. Pat. No. 4,683,194). The process utilizes sets of specific in vitro synthesized oligonucleotides to prime DNA synthesis. The design of the primers is dependent upon the sequences of DNA that are desired to be analyzed. The technique is carried out through many cycles (usually 20-50) of melting the template at high temperature, allowing the primers to anneal to complementary sequences within the template and then replicating the template with DNA polymerase.

[0161] The products of PCR reactions are analyzed by separation in agarose gels followed by ethidium bromide staining and visualization with UV transillumination. Alternatively, radioactive dNTPs can be added to the PCR in order to incorporate label into the products. In this case the products of PCR are visualized by exposure of the gel to x-ray film. The added advantage of radiolabeling PCR products is that the levels of individual amplification products can be quantitated.

[0162] Furthermore, single point mutations can be detected by modified PCR techniques such as the ligase chain reaction (“LCR”) and PCR-single strand conformational polymorphisms (“PCR-SSCP”) analysis. The PCR technique can also be sued to identify the level of expression of genes in extremely small samples of material, e.g., tissues or cells from a body. The technique is termed reverse transcription-PCR (“RT-PCR”).

[0163] In another embodiment, this invention concerns a method for altering oil phenotype in a plant which comprises:

[0164] (a) transforming a plant with a recombinant DNA construct comprising isolated nucleotide fragment comprising a nucleic acid sequence selected from the group consisting of:

[0165] (i) a nucleic acid sequence encoding a plant Hap3/Lec1 transcription factor having at least 70% identity based on the Clustal method of alignment when compared to a second polypeptide selected from the group consisting of SEQ ID NOs: 130 to 148, and SEQ ID NOs: 195 and 196;

[0166] (ii) the complement of the nucleic acid sequence of (iv);

[0167] (iii) the sequence of (iv) or (v) or a part thereof which is useful in antisense inhibition or co-suppression in a transformed plant;

[0168] (b) growing the transformed plant under conditions suitable for expression of the recombinant DNA construct; and

[0169] (c) selecting those transformed plants whose oil phenotype has been altered compared to the oil phenotype of an untransformed plant.

[0170] It is understood by one skilled in the art that other percent identity ranges may be useful in the above mentioned method. Useful percent identities would include, but not be limited to, 45%, 50%, 55%, 60%, 65%, 75%, 80%, 85%, 90%, 95% and all integer percentages from 45 to 100%.

[0171] In another aspect this invention concerns a method to isolate nucleic acid fragments associated with altering oil phenotype in a plant which comprises:

[0172] (a) comparing SEQ ID NOs: 130 to 148, and SEQ ID NOs: 195, 196, and 206 with other polypeptide sequences for the purpose of identifying polypeptides associated with altering oil phenotype in a plant;

[0173] (b) identifying the conserved sequences(s) or 4 or more amino acids obtained in step (a);

[0174] (c) making region-specific nucleotide probe(s) or oligomer(s) based on the conserved sequences identified in step (b); and

[0175] (d) using the nucleotide probe(s) or oligomer(s) of step (c) to isolate sequences associated with altering oil phenotype by sequence dependent protocols.

EXAMPLES

[0176] The present invention is further defined in the following Examples, in which parts and percentages are by weight and degrees are Celsius, unless otherwise stated. The disclosure of each reference set forth herein is incorporated herein by reference in its entirety.

Example 1

[0177] Composition of cDNA Libraries; Isolation and Sequencing of cDNA Clones

[0178] cDNA libraries representing mRNAs from various plant tissues were prepared. The characteristics of the libraries are described below.

2TABLE 2cDNA Libraries from Various PlantsLibraryTissueClonecbn10Corn Developing Kernel (Embryo andcbn10.pk0005.e6:fisEndosperm); 10 Days After Pollinationcbn10.pk0064.e6cc71se-aCorn Callus Type II Tissue, Somatic Embryocc71se-a.pk0002.e11:fisFormedcc71se-bCorn Callus Type II Tissue, Somatic Embryocc71se-b.pk0018.e4:fisFormedccaCorn Callus Type II Tissue, Undifferentiated,cca.pk0026.d6Highly Transformableccase-bCorn Callus Type II Tissue, Somatic Embryoccase-b.pk0003.b9:fisFormed, Highly Transformablecco1n.pk062.j7cco1n.pk086.d20:fiscco1nCorn Cob of 67 Day Old Plants Grown incco1n.pk0014.d4:fisGreen House*cco1n.pk055.o18cco1n.pk089.g17cco1n.pk068.f18:fiscde1cCorn (Zea Mays, B73) developing embryocde1c.pk003.o22:fis20 DAPced1nCorn (Zea mays, B73) developing embryocde1n.pk003.a520 DAP normalizedcde1n.pk001.n24:fiscdo1cCorn (Zea mays L.) ovary, 5 days aftercdolc.pk001.c1:fissilking (includes pedicel and glumes)ceb3Corn Embryo 20 Days After Pollinationceb3.pk0012.a7ceb5Corn Embryo 30 Days After Pollinationceb5.pk0081.b4cen3n.pk0164.a10cen3nCorn Endosperm 20 Days After Pollination*cen3n.pk0044.b8:fiscen3n.pk0112.e10:fischo1c.pk003.p17:fischo1c.pk003.n23cho1cCorn (Zea mays L., Alexho Synthetic High Oil)cho1c.pk004.b19:f15embryo 20 DAPcho1c.pk007.l21:fischo1c.pk001.l23:fischo1c.pk009.g10clm1fCorn (Zea mays, B73) leaf at V6-VT (full length)clm1f.pk001.k17clm1f.pk002.o13:fiscpd1cCorn (Zea mays L.) pooled BMS treated withcpd1c.pk011.15:fischemicals related to protein kinasescpd1c.pk008.e21cpf1cCorn (Zea mays L.) pooled BMS treated withcpf1c.pk006.e3:fischemicals related to protein synthesiscpj1cCorn (Zea mays L.) pooled BMS treated withcpj1c.pk005.m20:fischemicals related to membrane ionic forcecr1nCorn Root From 7 Day Old Seedlings*cr1n.pk0080.g6cse1cCorn (Zea mays L.) seedling at V2 stage treatedcse1c.pk001.h6with Ethylene collected at 6 hr, 23 hr, 72 hrcta1nCorn Tassel*cta1n.pk0070.f3:fiscta1n.pk0074.h11ctn1cCorn (Zea mays L., B73) night harvested tasselctn1c.pk002.o4ect1cCanna edulis Tubersect1c.pk001.k17:fisect1c.pk007.p18:fiseef1cEucalyptus tereticornis flower buds from adulteef1c.pk004.c8:fistreeetr1cCattail (Typha latifolia) rootetr1c.pk006.f9fdsMomordica charantia Developing Seedfds.pk0003.h5:fishss1cScierotinia infected sunflower plantshss1c.pk011.h10:fisncsCatalpa speciosa Developing Seedncs.pk0013.c4p0006Young shootp0006.cbysa51r:fisp001513 DAP embryop0015.cdpgu90r:fisp0015.cdpfm55r:fisp0016Tassel shoTassel shoots, pooled, 0.1-1.4 cmp0016.ctsbf56rbp0026Regenerating callus 5 days after auxin removalp0026.ccrab39rHi-II callus 223a, 1129ep0027GS3 shoot cultures that were transformed withp0027.cgsag51rPHP5869 and were maintained on 273T shootmultiplication medium since 3/17/94 (samplereceived on 5/29/96 for RNA prep). The originaltransformation was done on 11/6/93p0031CM45 shoot culture. It was initiated on 2/28/96p0031.ccmau15r:fisfrom seed derived meristems. The culture wasp0031.ccmbc81rmaintained on 273N medium.p0032Regenerating callus, 10 and 14 days after auxinp0032.crcac77r:fisremoval. Hi-II callus 223a, 1129e 10 days. Hi-IIcallus 223a, 1129e 14 daysp0037corn Root Worm infested V5 rootsp0037.crwbs90r:fisp0083.cldct11r:fisp00837 DAP whole kernelsp0083.cldeu68r:fisp0083.clder12rp0086P0067 screened 1; 11 DAP pericarpp0086.cbsaa24rp0118Night harvested, pooled stem tissue from thep0118.chsbc77r4-5 internodes subtending the tassel; V8-V12p0118.chsbh89rstages, Screened 1p0125Anther: Prophase I sceened 1p0125.czaab60rb:f15p0126Night harvested leaf tissue; V8-V10p0126.cnlau71r:fisp0134Hi-II callus 223a, 1129e, 10 days hi-II callusp0134.carah47r233a, 1129e, 14 dayspps1cPrickly poppy developing seedspps1c.pk001.h3:fispps1c.pk007.j21:fisrbm5cRice (Oryza sativa, Cypress) bran 10 days afterrbm5c.pk001.a19millingrca1cRice Nipponbare Callus.rca1c.pk007.b22:fisrca1n.pk029.n22rca1n.pk002.j3rca1nRice (Oryza sativa L., Nipponbare) callusrca1n.pk021.b20:fisnormalized.rca1n.pk004.j14:fisrca1n.pk026.m9rca1n.pk008.o5:fisr10n.pk096.h23r10n.pk0061.c8:fisr10nRice 15 Day Old Leaf*r10n.pk131.j17r10n.pk0015.a4:fisrlm3nRice (Oryza Sativa, YM) leaf mixture (rsr9)rlm3n.pk005.d20:fisnormalized at 45 C. for 24 hrs using 20 foldexcess of driverrlr2Rice (Oryza sativa L.) leaf (15 DAG) 2 hrs afterrlr2.pk0012.d2infection of strain 4360-R-62 (AVR2-YAMO);Resistantrlr24Rice Leaf 15 Days After Germination, 24 Hoursrlr24.pk0032.e10After Infection of Strain Magnaporthe grisea4360-R-62 (AVR2-YAMO); Resistantrls6Rice Leaf 15 Days After Germination, 6 Hoursrls6.pk0033.a9:fisAfter Infection of Strain Magnaporthe grisea4360-R-67 (AVR2-YAMO); Susceptiblerls72Rice Leaf 15 Days After Germination, 72 Hoursrls72.pk0023.c8:fisAfter Infection of Strain Magnaporthe grisea4360-R-67 (AVR2-YAMO); Susceptiblerr1Rice Root of Two Week Old Developingrr1.pk0039.d4:fisrr1.pk0003.a3:fisrr1.pk097.f22:fisrr1.pk0047.g12:fisrsl1n.pk002.g10:fisrsl1n.pk002.j2:fisrsl1nRice (Oryza sativa, YM) 15 day oldrsl1n.pk006.n24:fisnormalizedrsl1n.pk013.g2scb1cSoybean (Glycine max L., 2872) Embryogenicscb1c.pk004.n19:fissuspension culture subjected to4 bombardments and collected 12 hrs later.sde4cSoybean Developing Embryo (9-11 mm)sde4c.pk0001.a2:fissdp2c.pk003.o5:fissdp2cSoybean (Glycine max L.) developing podssdp2c.pk023.n6:fis6-7 mmsdp2c.pk029.k17:fissdp2c.pk044.e5:fissdp3c.pk018.b9:fissdp3cSoybean Developing Pods (8-9 mm)sdp3c.pk019.n1:fisspd4cSoybean (Glycine max L.) developing podssdp4c.pk009.e3s10-12 mmdp4c.pk016.e10sdr1fSoybean (Glycine max, Wye) 10 day old rootsdr1f.pk001.p7sds1fSoybean (Glycine max, Wye) 11 day oldsds1f.pk001.f7:fisseedling full length library using trehalosese1Soybean Embryo, 6 to 10 Days After Floweringse1.pk0042.d8:fisse2Soybean Embryo, 13 Days After Floweringse2.11d12:fisses2wSoybean Embryogenic Suspension 2 Weeksses2w.pk0015.a4:fisAfter Subcultureses2w.pk0035.a9:fisses2w.pk0012.d10:fisses4d.pk0037.e3:fisses4dSoybean Embryogenic Suspension 4 Days Afterses4d.pk0044.c12Subcultureses4d.pk0006.a12ses4d.pk0006.a12:fisses4d.pk0043.d10:fissfl1.pk0102.h8sf11.pk131.j19sfl1Soybean Immature Flowersfl1.pk135.g3sfl1.pk0029.h10:fissgc5cSoybean (Glycine max L., Wye) germanatingsgc5c.pk001.h16cotyledon (¾ yellow; 15-24 DAG)sgs1cSoybean Seeds 4 Hours After Germinationsgs1c.pk004.f19:fissgs4cSoybean (Glycine max L.) seeds 2 days aftersgs4c.pk004.j2germination.sgs4c.pk006.g6sgs4c.pk006.n21sic1cSoybean (Glycine max) pooled tissue of root,sic1c.pk003.o13:fisstem, and leaf with iron chlorosis conditionssic1c.pk003.o18:fissif1cSoybean (Glycine max) pooled tissue of basalsif1c.pk001.m16:fisstem and root infected with fusariumsls1cSoybean (Glycine max L., S1990) infected withsls1c.pk010.l1:fisSclerotinia sclerotiorum mycelium.sls1c.pk032.j4sls1cSoybean (Glycine max L., S1990) infected withsls1c.pk010.l1:fisSclerotinia sclerotiorum mycelium.sls1c.pk020.h24sls2cSoybean (Glycine max L., Manta) infected withsls2c.pk007.c23:fisSclerotinia sclerotiorum mycelium.sr1Soybean Rootsr1.pk0041.a11:fissr1.pk0049.c2srbScarlett runner bean (R. Goldberg)srb.08g04src1cSoybean 8 Day Old Root Infected With Cystsrc1c.pk003.o16:fisNematodesrc2c.pk025.b3:fissrc2cSoybean (Glycine max L., 437654) 8 day oldsrc2c.pk011.m12:fisroot inoculated with eggs of cyst Nematodesrc2c.pk009.g9:fis(Race 1) for 4 days.src2c.pk003.i13:fissrc3c.pk018.d10:fissr3c.pk011.g22src3cSoybean 8 Day Old Root Infected With Cystsrc3c.pk012.n16:fisNematodesrc3c.pk019.d4:fissrc3c.pk009.b15src3c.pk028.j21:fissrr1cSoybean 8-Day-Old Rootsrr1c.pk001.i24:fissrr3cSoybean 8-Day-Old Rootsrr3c.pk001.l10:fistlw1cTobacco (Nicotiana benthamiana) Leavestlw1c.pk006.o16Wounded by Abrasion and Harvested After1.5 Hour.vdb1cGrape (Vitis sp.) developing budvdb1c.pk001.m5:fisvmb1naGrape (Vitis sp.) midstage berries normalizedvmb1na.pk015.d18:fisvpl1cGrape (Vitis sp.) In vitro plantletsvpl1c.pk008.o5:fisvrr1cGrape (Vitis sp.) resistant rootsvrr1c.pk004.o20:fisvs1nVernonia Seed*vs1n.pk013.m13:fiswdelfWheat (Triticum aestivum, Hi Line) developingwde1f.pk003.h2:fisendosperm 2-7 DPAwdk2cWheat Developing Kernel, 7 Days After Anthesis.wdk2c.pk009.e4wdk2cWheat Developing Kernel, 7 Days After Anthesis.wdk2c.pk018.c16:fiswdk3cWheat Developing Kernel, 14 Days Afterwdk3c.pk023.h15:fisAnthesis.wdk5cWheat Developing Kernel, 30 Days Afterwdk5c.pk006.m13Anthesiswdk9nWheat (Triticum aestivu, Spring Wheat) kernelswdk9n.pk001.k53, 7, 14 and 21 days after anthesiswdr1fWheat (Triticum aestivum) developing root (fullwdr1f.pk003.b21:fislength)wds1fWheat developing seedling full lengthwds1f.pk002.p21:fiswia1cWheat (Triticum aestivum, Hi Line) immaturewia1c.pk001.d20:fisantherswkm1cWheat Kernel malted 55 Hours at 22 Degreeswkm1c.pk0002.d7:fisCelsiuswl1nWheat Leaf From 7 Day Old Seedling*wl1n.pk0114.f9wle1nWheat Leaf From 7 Day Old Etiolated Seedling*wle1n.pk0076.h7:fiswlk8Wheat Seedlings 8 Hours After Treatment Withwlk8.pk0001.e10:fisFungicide**wlm96.pk060.d5wlm96.pk037.k9:fiswlm96Wheat Seedlings 96 Hours After Inoculation Withwlm96.pk035.j11:fisErysiphe graminis f. sp triticiwlm96.pk0007.e4:fiswr1Wheat Root From 7 Day Old Seedlingwr1.pk0094.f2:fiswr1.pk0153.c7:fiswr1.pk148.f7:fiswre1nWheat Root From 7 Day Old Etiolatedwre1n.pk0066.e4:fisSeedling*wre1n.pk0143.h2:fis*These libraries were normalized essentially as described in U.S. Pat. No. 5,482,845, incorporated herein by reference. **Application of 6-iodo-3-propyl-2-propyloxy-4(3H)-quinazolinone; synthesis and methods of using this compound are described in U.S. Pat No. 5,747,497.

[0179] cDNA libraries may be prepared by any one of many methods available. For example, the cDNAs may be introduced into plasmid vectors by first preparing the cDNA libraries in Uni-ZAP™ XR vectors according to the manufacturer's protocol (Stratagene Cloning Systems, La Jolla, Calif.). The Uni-ZAP™ XR libraries are converted into plasmid libraries according to the protocol provided by Stratagene. Upon conversion, cDNA inserts will be contained in the plasmid vector pBluescript. In addition, the cDNAs may be introduced directly into precut Bluescript II SK(+) vectors (Stratagene) using T4 DNA ligase (New England Biolabs), followed by transfection into DH10B cells according to the manufacturer's protocol (GIBCO BRL Products). Once the cDNA inserts are in plasmid vectors, plasmid DNAs are prepared from randomly picked bacterial colonies containing recombinant pBluescript plasmids, or the insert cDNA sequences are amplified via polymerase chain reaction using primers specific for vector sequences flanking the inserted cDNA sequences. Amplified insert DNAs or plasmid DNAs are sequenced in dye-primer sequencing reactions to generate partial cDNA sequences (expressed sequence tags or “ESTs”; see Adams et al, (1991) Science 252:1651-1656). The resulting ESTs are analyzed using a Perkin Elmer Model 377 fluorescent sequencer.

[0180] Full-insert sequence (FIS) data is generated utilizing a modified transposition protocol. Clones identified for FIS are recovered from archived glycerol stocks as single colonies, and plasmid DNAs are isolated via alkaline lysis. Isolated DNA templates are reacted with vector primed M13 forward and reverse oligonucleotides in a PCR-based sequencing reaction and loaded onto automated sequencers. Confirmation of clone identification is performed by sequence alignment to the original EST sequence from which the FIS request is made.

[0181] Confirmed templates are transposed via the Primer Island transposition kit (PE Applied Biosystems, Foster City, Calif.) which is based upon the Saccharomyces cerevisiae Ty1 transposable element (Devine and Boeke (1994) Nucleic Acids Res. 22:3765-3772). The in vitro transposition system places unique binding sites randomly throughout a population of large DNA molecules. The transposed DNA is then used to transform DH10B electro-competent cells (Gibco BRL/Life Technologies, Rockville, Md.) via electroporation. The transposable element contains an additional selectable marker (named DHFR; Fling and Richards (1983) Nucleic Acids Res. 11:5147-5158), allowing for dual selection on agar plates of only those subclones containing the integrated transposon. Multiple subclones are randomly selected from each transposition reaction, plasmid DNAs are prepared via alkaline lysis, and templates are sequenced (ABI Prism dye-terminator ReadyReaction mix) outward from the transposition event site, utilizing unique primers specific to the binding sites within the transposon.

[0182] Sequence data is collected (ABI Prism Collections) and assembled using Phred/Phrap (P. Green, University of Washington, Seattle). Phrep/Phrap is a public domain software program which re-reads the ABI sequence data, re-calls the bases, assigns quality values, and writes the base calls and quality values into editable output files. The Phrap sequence assembly program uses these quality values to increase the accuracy of the assembled sequence contigs. Assemblies are viewed by the Consed sequence editor (D. Gordon, University of Washington, Seattle).

[0183] In some of the clones the cDNA fragment corresponds to a portion of the 3′-terminus of the gene and does not cover the entire open reading frame. In order to obtain the upstream information one of two different protocols are used. The first of these methods results in the production of a fragment of DNA containing a portion of the desired gene sequence while the second method results in the production of a fragment containing the entire open reading frame. Both of these methods use two rounds of PCR amplification to obtain fragments from one or more libraries. The libraries some times are chosen based on previous knowledge that the specific gene should be found in a certain tissue and some times are randomly-chosen. Reactions to obtain the same gene may be performed on several libraries in parallel or on a pool of libraries. Library pools are normally prepared using from 3 to 5 different libraries and normalized to a uniform dilution. In the first round of amplification both methods use a vector-specific (forward) primer corresponding to a portion of the vector located at the 5′-terminus of the clone coupled with a gene-specific (reverse) primer. The first method uses a sequence that is complementary to a portion of the already known gene sequence while the second method uses a gene-specific primer complementary to a portion of the 3′-untranslated region (also referred to as UTR). In the second round of amplification a nested set of primers is used for both methods. The resulting DNA fragment is ligated into a pBluescript vector using a commercial kit and following the manufacturer's protocol. This kit is selected from many available from several vendors including Invitrogen (Carlsbad, Calif.), Promega Biotech (Madison, Wis.), and Gibco-BRL (Gaithersburg, Md.). The plasmid DNA is isolated by alkaline lysis method and submitted for sequencing and assembly using Phred/Phrap, as above.

Example 2

[0184] Identification of cDNA Clones

[0185] cDNA clones encoding proteins involved in altering plant oil traits were identified by gene profiling (see Example 7) and by conducting BLAST (Basic Local Alignment Search Tool; Altschul et al (1993) J. Mol. Biol. 215:403-410; see also www.ncbi.nlm.nih.gov/BLAST/) searches for similarity to sequences contained in the BLAST “nr” database (comprising all non-redundant GenBank CDS translations, sequences derived from the 3-dimensional structure Brookhaven Protein Data Bank, the last major release of the SWISS-PROT protein sequence database, EMBL, and DDBJ databases). The cDNA sequences obtained in Example 1 were analyzed for similarity to all publicly available DNA sequences contained in the “nr” database using the BLASTN algorithm provided by the National Center for Biotechnology Information (NCBI). The DNA sequences were translated in all reading frames and compared for similarity to all publicly available protein sequences contained in the “nr” database using the BLASTX algorithm (Gish and States (1993) Nat. Genet. 3:266-272) provided by the NCBI. For convenience, the P-value (probability) of observing a match of a cDNA sequence to a sequence contained in the searched databases merely by chance as calculated by BLAST are reported herein as “pLog” values, which represent the negative of the logarithm of the reported P-value. Accordingly, the greater the pLog value, the greater the likelihood that the cDNA sequence and the BLAST “hit” represent homologous proteins.

[0186] ESTs submitted for analysis are compared to the genbank database as described above. ESTs that contain sequences more 5- or 3-prime can be found by using the BLASTn algorithm (Altschul et al (1997) Nucleic Acids Res. 25:3389-3402.) against the DuPont proprietary database comparing nucleotide sequences that share common or overlapping regions of sequence homology. Where common or overlapping sequences exist between two or more nucleic acid fragments, the sequences can be assembled into a single contiguous nucleotide sequence, thus extending the original fragment in either the 5 or 3 prime direction. Once the most 5-prime EST is identified, its complete sequence can be determined by Full Insert Sequencing as described in Example 1. Homologous genes belonging to different species can be found by comparing the amino acid sequence of a known gene (from either a proprietary source or a public database) against an EST database using the tBLASTn algorithm. The tBLASTn algorithm searches an amino acid query against a nucleotide database that is translated in all 6 reading frames. This search allows for differences in nucleotide codon usage between different species, and for codon degeneracy.

Example 3

[0187] Characterization of cDNA Clones Encoding Proteins Involved in Altering Oil

Phenotypes

[0188] The BLASTX search using the EST sequences from clones listed in Table 3 revealed similarity of the polypeptides encoded by the cDNAs to Hap2 homologs, Hap5 homologs, and Lec1 transcription factors from various species including Arabidopsis thaliana, rice (Oryza sativa), corn (Zea mays), soybean (Glycine max), cucmber (Cucumis sativus), Sordaria (Sordaria macrospora), sesame (Sesamum indicum), grape (Vitis sp.), Brassica (Brassica napus), and tobacco (Nicotiana tabacum). Shown in Table 3 are the BLAST results for individual ESTs (“EST”), the sequences of the entire cDNA inserts comprising the indicated cDNA clones (“FIS”), the sequences of contigs assembled from two or more ESTs (“Contig”), sequences of contigs assembled from an FIS and one or more ESTs (“Contig*”), or sequences encoding an entire protein derived from an FIS, a contig, or an FIS and PCR (“CGS”):

3TABLE 3BLAST Results for Sequences Encoding Polypeptides Homologousto Proteins Involved in Altering Oil PhenotypesSEQ IDNO.Gene NameCloneHomologGenbank #pLOG2Hap2ancs.pk0013.c4No hits—4Hap2cetr1c.pk006.f9No hits—6Hap2avmb1na.pk015.d18Arabidopsis112825978.18Hap2avpl1c.pk008.o5:fisGrape714124391.210Hap2cvdb1c.pk001.m5:fisRice748956538.012Hap2ccho1c.pk004.b19:fisRice748956594.314Hap2cp0015.cdpgu90r:fisRice748956596.216Hap2acta1n.pk0070.f3:fisRice748956538.118Hap2acco1n.pk0014.d4:fisArabidopsis663477437.220Hap2acco1n.pk086.d20:fisArabidopsis663477436.322Hap2bp0126.cnlau71r:fisRice748956523.724Hap2bp0104.cabav52rRice748956516.726Hap2bcho1c.pk007.l21:fisRice748956535.0contig of:cca.pk0026.d628Hap2ccen3n.pk0061.e10:fisRice748956543.5cen3n.pk0135.c2cho1c.pk001.n24p0092.chwae40r30Hap2ccpf1c.pk006.e3:fisRice748956544.0contig of:Rice748956532Hap2ccr1n.pk0080.g635.0p0003.cgpge51r34Hap2cp0015.cdpfm55r:fisArabidopsis458755926.436Hap2p0083.cldct11r:fisRice748956591.438Hap2p0083.cldeu68r:fisRice748956514.240Hap2apps1c.pk001.h3:fisArabidopsis929399745.542Hap2cpps1c.pk007.j21:fisArabidopsis590307253.744Hap2rr1.pk0030.f7:fisRice7489565identical46Hap2ar1s72.pk0023.c8:fisArabidopsis929399736.548Hap2arca1n.pk002.c15Grape71412437.750Hap2ards3c.pk001.g9Rice748956518.252Hap2brca1n.pk002.j3:fisRice748956526.054Hap2crca1n.pk029.n22:fisArabidopsis877847029.256Hap2br10n.pk131.j17Rice748956510.558Hap2asdp3c.pk018.b9:fiSArabidopsis239852174.560Hap2asfl1.pk0102.h8Grape714124336.762Hap2asrr3c.pk001.l10:fisBrassica158655148.764Hap2asdp2c.pk003.o5:fiSArabidopsis663477453.066Hap2bsif1c.pk001.m16:fisArabidopsis6714441180.068Hap2csrc1c.pk003.o16:fisRice748956533.570Hap2csrc3c.pk012.m6:fisRice748956531.572Hap2ahss1c.pk011.h10:fisArabidopsis929399748.774Hap2cwr1.pk0094.f2:fisRice748956592.776Hap2awre1n.pk0143.h2:fisArabidopsis663477435.078Hap2bwds1f.pk002.p21:fisArabidopsis671444126.5contig of:80Hap2bwdi1c.pk002.b10Rice748956538.5wr1.pk0153.c7:fis82Hap2cwre1n.pk0066.e4:fisRice748956542.784Hap5cect1c.pk001.k17:fisRice525726057.086Hap5avrr1c.pk004.o20:fisArabidopsis652309093.088Hap5aclm1f.pk001.k17:fisArabidopsis652309066.790Hap5bcde1n.pk003.a5:fisArabidopsis377657557.092Hap5bcen3n.pk0164.a10:fisArabidopsis377657557.094Hapsbp0118.chsbc77rArabidopsis377657558.596Hap5ccco1n.pk055.o18Rice525726041.098Hap5ccho1c.pk001.l23:fisRice525726082.0100Hap5ccse1c.pk001.h6:fisRice525726086.4102Hap5arlm3n.pk005.d20:fisArabidopsis652309066.7104Hap5brr1.pk0003.a3:fisArabidopsis628905758.5106Hap5brr1.pk0039.d4:fisArabidopsis377657557.2108Hap5crca1n.pk021.b20:fisRice525726074.0110Hap5asdp2c.pk029.k17:fisArabidopsis652309090.5112Hap5asdp2c.pk044.e5:fisArabidopsis652309092.4114Hap5bsgs4c.pk004.j2Arabidopsis377657518.5116Hap5bsrc3c.pk002.h4:fisArabidopsis628905761.1118Hap5bsrc3c.pk009.b15:fisArabidopsis628905761.5120Hap5bsrc3c.pk019.d4:fisArabidopsis605636851.5122Hap5csls1c.pk032.j4:fisArabidopsis628905774.5124Hap5wdk2c.pk009.e4:fisRice525726020.0Contig of:126Hap5aw1m96.pk036.j11Arabidopsis975828819.7w1m96.pk060.d5:fis128Hap5cwle1n.pk0076.h7:fisRice525726082.0130Lec1eas1c.pk003.e16Arabidopsis975879549.2132Lec1fds1n.pk008.m14Arabidopsis975879546.1134Lec1p0015.cdpg75rb:fisArabidopsis975879545.4136Lec1p0083.clder12r:fisArabidopsis655273835.2138Lec1pps1c.pk002.l19Arabidopsis975879545.2Contig of:140Lec1scb1c.pk004.j10Arabidopsis975879547.4se1.pk0042.d8:fis142Lec1se2.11d12:fisArabidopsis975879552.2144Lec1ses2w.pk0015.a4:fisArabidopsis975879543.7146Lec1vs1n.pk013.m13:fisArabidopsis975879553.1148Lec1wdk3c.pk023.h15:fisArabidopsis975879536.7150Lec1-CCAATect1c.pk007.p18:fisZea mays2238044.7152Lec1-CCAATfds.pk0003.h5:fisArabidopsis672948557.7154Lec1-CCAATeef1c.pk004.c8:fisZea mays2238061.7156Lec1-CCAATcbn10.pk0005.e6:fisZea mays2238072.2158Lec1-CCAATp0006.cbysa51r:fisArabidopsis224481055.5160Lec1-CCAATrl0n.pk0061.c8:fisZea mays2238046.5162Lec1-CCAATrsl1n.pk002.g10:fisZea mays2238068.7164Lec1-CCAATses4d.pk0037.e3:fisArabidopsis239852949.0166Lec1-CCAATsrc2c.pk003.i13:fisArabidopsis373829341.1168Lec1-CCAATsrc2c.pk011.m12:fisArabidopsis672948562.0170Lec1-CCAATsrc2c.pk025.b3:fisZea mays2238045.5172LecI-CCAATsrc3c.pk028.j21:fisZea mays2238054.3174Lec1-CCAATwkm1c.pk0002.d7:fisZea mays2238079.5176Lec1-CCAATwlk8.pk0001.e10:fisArabidopsis239852952.7178LecI-CCAATwlm96.pk037.k9:fisZea mays2238073.5206Lec1rice genome seqOryza sativa7378310180208Hap2ncs.pk0013.c4:fisArabidopsis929399746.7210Hap2p0117.chcln94r:fisOryza sativa148956526.0212Hap2rdi2c.pk011.f19:fisOryza sativa148956545.0214Hap2sfl1.pk0101.g7:fisVitis sp.714124338.4216Hap2wdi1c.pk002.b10:fisOryza sativa148956540.3221Hap5sgs4c.pk004.j2:fisArabidopsis1522348269.0

[0189] The sequence of the entire cDNA insert in the clones listed in Table 3 was determined. Further sequencing and searching of the DuPont proprietary database allowed the identification of other corn, rice, soybean and/or wheat clones encoding polypetides involved in altering oil phenotypes. The BLASTX search using the sequences from clones listed in Table 4 revealed similarity of the polypeptides encoded by the various cDNAs from plant and fungal species (noted by their NCBI General Identifier No. in Tables 3 and 4). Shown in Table 4 are the BLAST results for individual ESTs (“EST”), the sequences of the entire cDNA inserts comprising the indicated cDNA clones (“FIS”), sequences of contigs assembled from two or more ESTs (“Contig”), sequences of contigs assembled from an FIS and one or more ESTs (“Contig*”), or sequences encoding the entire protein derived from an FIS, a contig, or an FIS and PCR (“CGS”):

4TABLE 4Percent Identity of Amino Acid Sequences Deduced From the NucleotideSequences of cDNA ClonesEncoding Polypeptides Homologous to Polypeptides Involved inAltering Plant Oil PhenotypesSEQ ID NO.Accession No. (SEQ ID NO)Percent Identity21586551 (187)23.4%47489565 (181)27.4%611282597 (179) 22.1%107489565 (181)36.1%127489565 (181)67.2%147489565 (181)70.6%167489565 (181)33.2%186634774 (182)40.1%206634774 (182)39.1%227489565 (181)28.2%247489565 (181)53.2%267489565 (181)34.0%287489565 (181)39.5%307489565 (181)39.5%327489565 (181)35.5%344587559 (202)54.1%367489565 (181)67.2%387489565 (181)29.0%409293997 (217)31.5%425903072 (184)35.3%465903072 (184)33.7%487141243 (180)34.5%507489565 (181)35.7%527489565 (181)27.2%548778470 (185)40.5%567489565 (181)22.1%582398521 (186)49.1%607141243 (180)40.9%621586551 (187)37.8%646634774 (182)49.2%666714441 (188)32.5%687489565 (181)32.4%707489565 (181)31.1%729293997 (217)40.6%747489565 (181)68.5%766634774 (182)36.5%786714441 (188)23.7%807489565 (181)34.5%827489565 (181)37.4%845257260 (189)62.9%866523090 (190)77.7%886523090 (190)53.8%903776575 (191)50.7%923776575 (191)51.6%943776575 (191)60.0%965257260 (189)62.7%985257260 (189)75.0%1005257260 (189)77.5%1026523090 (190)53.8%1046289057 (192)60.6%1063776575 (191)52.1%1085257260 (189)77.9%1106523090 (190)70.3%1126523090 (190)70.7%1143776575 (191)35.7%1166289057 (192)53.2%1186289057 (192)52.8%1206056368 (193)73.0%1226289057 (192)57.1%1245257260 (189)27.3%1269758288 (194)46.3%1285257260 (189)74.9%1309758795 (196)49.0%1329758795 (196)49.7%1349758795 (196)49.8%1366552738 (195)38.9%2089293997 (217)34.9%2107489565 (218)28.6%2127489565 (218)35.7%2147141243 (219)42.3%2167489565 (218)34.9%22115223482 (222) 64.8%

[0190] Sequence alignments and percent identity calculations were performed using the Megalign program of the LASERGENE bioinformatics computing suite (DNASTAR Inc., Madison, Wis.). Multiple alignment of the sequences was performed using the Clustal method of alignment (Higgins and Sharp (1989) CABIOS. 5:151-153) with the default parameters (GAP PENALTY=10, GAP LENGTH PENALTY=10). Default parameters for pairwise alignments using the Clustal method were KTUPLE 1, GAP PENALTY=3, WINDOW=5 and DIAGONALS SAVED=5. Sequence alignments and BLAST scores and probabilities indicate that the nucleic acid fragments comprising the instant cDNA clones encode a substantial portion of cDNAs to receptor protein kinases, MEK3 homologs, Hap2 homologs, LIP 15 homologs, calcium EF-hand proteins, ATP citrate lyase, glucose metabolism proteins such as SNF1 homologs, Lec1 transcription factors, and seed developmentally regulated transcription factors such as CKC (Aintegumenta-like) homologs.

Example 4

[0191] Expression of Recombinant DNA Constructs in Monocot Cells

[0192] A recombinant DNA construct comprising a cDNA encoding the instant polypeptides in sense orientation with respect to the maize 27 kD zein promoter that is located 5′ to the cDNA fragment, and the 10 kD zein 3′ end that is located 3′ to the cDNA fragment, can be constructed. The cDNA fragment of this gene may be generated by polymerase chain reaction (PCR) of the cDNA clone using appropriate oligonucleotide primers. Cloning sites (Ncol or Smal) can be incorporated into the oligonucleotides to provide proper orientation of the DNA fragment when inserted into the digested vector pML103 as described below. Amplification is then performed in a standard PCR. The amplified DNA is then digested with restriction enzymes Ncol and SmaI and fractionated on an agarose gel. The appropriate band can be isolated from the gel and combined with a 4.9 kb NcoI-SmaI fragment of the plasmid pML103. Plasmid pML103 has been deposited under the terms of the Budapest Treaty at ATCC (American Type Culture Collection, 10801 University Blvd., Manassas, Va. 20110-2209), and bears accession number ATCC 97366. The DNA segment from pML103 contains a 1.05 kb SaII-NcoI promoter fragment of the maize 27 kD zein gene and a 0.96 kb SmaI-SaII fragment from the 3′ end of the maize 10 kD zein gene in the vector pGem9Zf(+) (Promega). Vector and insert DNA can be ligated at 15° C. overnight, essentially as described (Maniatis). The ligated DNA may then be used to transform E. coli XL1-Blue (Epicurian Coli XL-1 Blue™; Stratagene). Bacterial transformants can be screened by restriction enzyme digestion of plasmid DNA and limited nucleotide sequence analysis using the dideoxy chain termination method (Sequenase™ DNA Sequencing Kit; U.S. Biochemical). The resulting plasmid construct would comprise a recombinant DNA construct encoding, in the 5′ to 3′ direction, the maize 27 kD zein promoter, a cDNA fragment encoding the instant polypeptides, and the 10 kD zein 3′ region.

[0193] The recombinant DNA construct described above can then be introduced into corn cells by the following procedure. Immature corn embryos can be dissected from developing caryopses derived from crosses of the inbred corn lines H99 and LH132. The embryos are isolated 10 to 11 days after pollination when they are 1.0 to 1.5 mm long. The embryos are then placed with the axis-side facing down and in contact with agarose-solidified N6 medium (Chu et al (1975) Sci. Sin. Peking 18:659-668). The embryos are kept in the dark at 27° C. Friable embryogenic callus consisting of undifferentiated masses of cells with somatic proembryoids and embryoids borne on suspensor structures proliferates from the scutellum of these immature embryos. The embryogenic callus isolated from the primary explant can be cultured on N6 medium and sub-cultured on this medium every 2 to 3 weeks.

[0194] The plasmid, p35S/Ac (obtained from Dr. Peter Eckes, Hoechst Ag, Frankfurt, Germany) may be used in transformation experiments in order to provide for a selectable marker. This plasmid contains the Pat gene (see European Patent Publication 0 242 236) which encodes phosphinothricin acetyl transferase (PAT). The enzyme PAT confers resistance to herbicidal glutamine synthetase inhibitors such as phosphinothricin. The pat gene in p35S/Ac is under the control of the 35S promoter from Cauliflower Mosaic Virus (Odell et al (1985) Nature 313:810-812) and the 3′ region of the nopaline synthase gene from the T-DNA of the Ti plasmid of Agrobacterium tumefaciens.

[0195] The particle bombardment method (Klein et al (1987) Nature 327:70-73) may be used to transfer genes to the callus culture cells. According to this method, gold particles (1 μm in diameter) are coated with DNA using the following technique. Ten μg of plasmid DNAs are added to 50 μL of a suspension of gold particles (60 mg per ml). Calcium chloride (50 μL of a 2.5 M solution) and spermidine free base (20 μL of a 1.0 M solution) are added to the particles. The suspension is vortexed during the addition of these solutions. After 10 minutes, the tubes are briefly centrifuged (5 sec at 15,000 rpm) and the supernatant removed. The particles are resuspended in 200 μL of absolute ethanol, centrifuged again and the supernatant removed. The ethanol rinse is performed again and the particles resuspended in a final volume of 30 μL of ethanol. An aliquot (5 μL) of the DNA-coated gold particles can be placed in the center of a Kapton™ flying disc (Bio-Rad Labs). The particles are then accelerated into the corn tissue with a Biolistic™ PDS-1000/He (Bio-Rad Instruments, Hercules Calif.), using a helium pressure of 1000 psi, a gap distance of 0.5 cm and a flying distance of 1.0 cm.

[0196] For bombardment, the embryogenic tissue is placed on filter paper over agarose-solidified N6 medium. The tissue is arranged as a thin lawn and covered a circular area of about 5 cm in diameter. The petri dish containing the tissue can be placed in the chamber of the PDS-1000/He approximately 8 cm from the stopping screen. The air in the chamber is then evacuated to a vacuum of 28 inches of Hg. The macrocarrier is accelerated with a helium shock wave using a rupture membrane that bursts when the He pressure in the shock tube reaches 1000 psi.

[0197] Seven days after bombardment the tissue can be transferred to N6 medium that contains bialophos (5 mg per liter) and lacks casein or proline. The tissue continues to grow slowly on this medium. After an additional 2 weeks the tissue can be transferred to fresh N6 medium containing bialophos. After 6 weeks, areas of about 1 cm in diameter of actively growing callus can be identified on some of the plates containing the bialophos-supplemented medium. These calli may continue to grow when sub-cultured on the selective medium.

[0198] Plants can be regenerated from the transgenic callus by first transferring clusters of tissue to N6 medium supplemented with 0.2 mg per liter of 2,4-D. After two weeks the tissue can be transferred to regeneration medium (Fromm et al (1990) Bio/Technology 8:833-839).

Example 5

[0199] Expression of Recombinant DNA Constructs in Dicot Cells

[0200] A seed-specific expression cassette composed of the promoter and transcription terminator from the gene encoding the β subunit of the seed storage protein phaseolin from the bean Phaseolus vulgaris (Doyle et al (1986) J. Biol. Chem. 261:9228-9238) can be used for expression of the instant polypeptides in transformed soybean. The phaseolin cassette includes about 500 nucleotides upstream (5′) from the translation initiation codon and about 1650 nucleotides downstream (3′) from the translation stop codon of phaseolin. Between the 5′ and 3′ regions are the unique restriction endonuclease sites Nco I (which includes the ATG translation initiation codon), Sma I, Kpn I and Xba I. The entire cassette is flanked by Hind III sites.

[0201] The cDNA fragment of this gene may be generated by polymerase chain reaction (PCR) of the cDNA clone using appropriate oligonucleotide primers. Cloning sites can be incorporated into the oligonucleotides to provide proper orientation of the DNA fragment when inserted into the expression vector. Amplification is then performed as described above, and the isolated fragment is inserted into a pUC18 vector carrying the seed expression cassette.

[0202] Soybean embryos may then be transformed with the expression vector comprising sequences encoding the instant polypeptides. To induce somatic embryos, cotyledons, 3-5 mm in length dissected from surface sterilized, immature seeds of the soybean cultivar A2872, can be cultured in the light or dark at 26° C. on an appropriate agar medium for 6-10 weeks. Somatic embryos which produce secondary embryos are then excised and placed into a suitable liquid medium. After repeated selection for clusters of somatic embryos which multiplied as early, globular staged embryos, the suspensions are maintained as described below.

[0203] Soybean embryogenic suspension cultures can be maintained in 35 mL liquid media on a rotary shaker, 150 rpm, at 26° C. with florescent lights on a 16:8 hour day/night schedule. Cultures are subcultured every two weeks by inoculating approximately 35 mg of tissue into 35 mL of liquid medium.

[0204] Soybean embryogenic suspension cultures may then be transformed by the method of particle gun bombardment (Klein et al (1987) Nature (London) 327:70-73, U.S. Pat. No. 4,945,050). A DuPont Biolistic™ PDS1000/HE instrument (helium retrofit) can be used for these transformations.

[0205] A selectable marker gene which can be used to facilitate soybean transformation is a recombinant DNA construct composed of the 35S promoter from Cauliflower Mosaic Virus (Odell et al (1985) Nature 313:810-812), the hygromycin phosphotransferase gene from plasmid pJR225 (from E. coli; Gritz et al(1983) Gene 25:179-188) and the 3′ region of the nopaline synthase gene from the T-DNA of the Ti plasmid of Agrobacterium tumefaciens. The seed expression cassette comprising the phaseolin 5′ region, the fragment encoding the instant polypeptides and the phaseolin 3′ region can be isolated as a restriction fragment. This fragment can then be inserted into a unique restriction site of the vector carrying the marker gene.

[0206] To 50 μL of a 60 mg/mL 1 μm gold particle suspension is added (in order): 5 μL DNA (1 μg/μL), 20 μL spermidine (0.1 M), and 50 μL CaCl2 (2.5 M). The particle preparation is then agitated for three minutes, spun in a microfuge for 10 seconds and the supernatant removed. The DNA-coated particles are then washed once in 400 μL 70% ethanol and resuspended in 40 μL of anhydrous ethanol. The DNA/particle suspension can be sonicated three times for one second each. Five μL of the DNA-coated gold particles are then loaded on each macro carrier disk.

[0207] Approximately 300-400 mg of a two-week-old suspension culture is placed in an empty 60×15 mm petri dish and the residual liquid removed from the tissue with a pipette. For each transformation experiment, approximately 5-10 plates of tissue are normally bombarded. Membrane rupture pressure is set at 1100 psi and the chamber is evacuated to a vacuum of 28 inches mercury. The tissue is placed approximately 3.5 inches away from the retaining screen and bombarded three times. Following bombardment, the tissue can be divided in half and placed back into liquid and cultured as described above.

[0208] Five to seven days post bombardment, the liquid media may be exchanged with fresh media, and eleven to twelve days post bombardment with fresh media containing 50 mg/mL hygromycin. This selective media can be refreshed weekly. Seven to eight weeks post bombardment, green, transformed tissue may be observed growing from untransformed, necrotic embryogenic clusters. Isolated green tissue is removed and inoculated into individual flasks to generate new, clonally propagated, transformed embryogenic suspension cultures. Each new line may be treated as an independent transformation event. These suspensions can then be subcultured and maintained as clusters of immature embryos or regenerated into whole plants by maturation and germination of individual somatic embryos.

Example 6

[0209] Expression Vector for Plant Transformation by Particle Gun Bombardment.

[0210] A seed specific gene expression cassette was used for making recombinant DNA constructs for expression of candidate genes in corn. The expression cassette is composed of the 0.9 kb oleosin promoter, the intron 1 of the maize shrunken 1 gene and adjacent exon (Vasil et al, 1989, Plant Physiol 91: 1575-1579; Mascarenhas et al, 1990, Plant Mol Biol 15:913-920) and 3′ transcription termination region from the nopaline synthase (Nos) gene. In between the exon adjacent to the shrunken 1 gene and the nopaline synthase (Nos) gene are unique restriction endonuclease sites MfeI and XmaI. This vector has been designated pBN256 (REF. Jennie Shen's patent). pMUT256 refers to a pBN256 plasmid in which a EcoRI site has been removed by site directed mutagenesis. A modified version of pMUT256, designated pMUT256e was modified by additon of a synthetic multiple cloning site. The synthetic polylinker was generated by annealing of oligos (5′-acagtacagtacagtacagtacagt-3′) and (5′-actgtactgtactgtacgtgactgt-3′) [SEQ ID NOs: 430 and 431, respectively] and subsequent subcloning into the pMut256 open with MfeI and XmaI. Additional expression cassettes/vectors will be described in reference to specific examples where they have been used (see below).

Example 7

[0211] Isolation and Cloning of Candidate Genes into Embryo-specific Plant Expression Vectors.

[0212] HAP3/LEC1 (Heme-Activated Protein 3/Leafy Cotyledon 1):

[0213] A full length clone (p0015.cdpgp75rb, SEQ ID NOs: 263) for the corn homolog of the HAP3/Lec1 gene was obtained from Dupont/Pioneer EST Database. The ORF of maize HAP3/Lec1 (a 1 kb SaII/HpaI fragment, PCT Application No. WO 00/28058, published on May 18, 2000) was moved into an expression cassette containing a maize oleosin promoter (a 0.9 kb BamHI/XhoI fragment, PCT Application No. WO 99/64579, published on Dec. 16, 1999) and a polyadenylation sequence from the Agrobacterium nopaline synthase gene. This expression cassette was then subcloned adjacent to a 35S::Bar expression cassette (Sidorenko et al (2000) Plant J 22:471-482). The resulting expression cassettes flanked by T-DNA border sequences were then mobilized into the Agrobacterium “super-binary” vector (Komari, 1990) using electroporation. Additional constructs were made to confer expression patterns different from those obtained with the oleosin promoter. A ubiquitin promoter (UBI, Christensen et al (1992) Plant Mol Biol 18:675-680), a lipid transfer protein (LTP) promoter (U.S. Pat. No. 5,525,716), and a gamma zein promoter (GZP) (Boronat et al (1986) Plant Science 47: 95-102) were each fused to Lec1 as described above for the oleosin promoter. The two transcription units, LTP-Lec1 and GZP-Lec1, were combined into one expression construct next to the 35S:Bar expression construct and flanked by T-DNA border sequences (as described above).

[0214] HAP2 (Heme-Activated Protein 2):

[0215] A full length clone (cho1c.pk006.b14, a 30 nucleotide shorter cDNA than cho1c.pk004.b19:fis, shown in SEQ ID NO: 27) for the corn homolog of the HAP2 gene was obtained from Dupont/Pioneer EST Database. The ApoI/ApaI 1.1 kb fragment of cho1c.pk006.b14 was isolated and subcloned into pMUT256e opened by digestion with EcoRI/ApaI. One clone was selected for corn transformation by restriction digestion analysis for correct insert size. Subcloning artifacts were excluded by 5′ and 3′ sequence of the vector-insert boundaries.

[0216] HAP5 (Heme-Activated Protein 5):

[0217] A full length clone (cho1c.pk001.I23, shown in SEQ ID NO: 113) for the corn homolog of HAP5 gene was obtained from Dupont/Pioneer EST Database. The EcoRI/ApaI 1.1 kb fragment of cho1c.pk001.I23 was isolated and subcloned into pMUT256e opened by digestion with EcoRI/ApaI. One clone was selected for corn transformation after restriction digestion analysis for correct insert size. Subcloning artifacts were excluded by 5′ and 3′ sequence of the vector-insert boundaries.

Example 8

[0218] Transformation of Immature Embryos BY Particle Bombardment and Regeneration of Corn Plants

[0219] Immature maize embryos from greenhouse donor plants are bombarded with a plasmid containing the gene of the invention operably linked to a weak promoter, such as the nos promoter, or an inducible promoter, such as ln2, plus a plasmid containing the selectable marker gene PAT (Wohileben et al (1988) Gene 70:25-37) that confers resistance to the herbicide Bialaphos. Transformation is performed as follows. The ears are surface sterilized in 30% Chloral bleach plus 0.5% Micro detergent for 20 minutes, and rinsed two times with sterile water. The immature embryos are excised and placed embryo axis side down (scutellum side up), 25 embryos per plate. These are cultured on 560 L medium 4 days prior to bombardment in the dark. Medium 560 L is an N6-based medium containing Eriksson's vitamins, thiamine, sucrose, 2,4-D, and silver nitrate. The day of bombardment, the embryos are transferred to 560 Y medium for 4 hours and are arranged within the 2.5-cm target zone. Medium 560Y is a high osmoticum medium (560 L with high sucrose concentration). A plasmid vector comprising the gene of the invention operably linked to the selected promoter is constructed. This plasmid DNA plus plasmid DNA containing a PAT selectable marker is precipitated onto 1.1 μm (average diameter) tungsten pellets using a CaCl2 precipitation procedure as follows: 100 μl prepared tungsten particles in water, 10 μl (1 μg) DNA in TrisEDTA buffer (1 μg total), 100 μl 2.5 M CaCl2, 10 μl 0.1 M spermidine. Each reagent is added sequentially to the tungsten particle suspension, while maintained on the multitube vortexer. The final mixture is sonicated briefly and allowed to incubate under constant vortexing for 10 minutes. After the precipitation period, the tubes are centrifuged briefly, liquid removed, washed with 500 ml 100% ethanol, and centrifuged for 30 seconds. Again the liquid is removed, and 105 μl 100% ethanol is added to the final tungsten particle pellet. For particle gun bombardment, the tungsten/DNA particles are briefly sonicated and 10 μl spotted onto the center of each macrocarrier and allowed to dry about 2 minutes before bombardment. The sample plates are bombarded at level #4 in particle gun #HE34-1 or #HE34-2. All samples receive a single shot at 650 PSI, with a total of ten aliquots taken from each tube of prepared particles/DNA. Following bombardment, the embryos are kept on 560Y medium, an N6 based medium, for 2 days, then transferred to 560R selection medium, an N6 based medium containing 3 mg/liter Bialaphos, and subcultured every 2 weeks. After approximately 10 weeks of selection, selection-resistant callus clones are sampled for PCR and activity of the gene of interest. Positive lines are transferred to 288J medium, an N6 based medium with lower sucrose and hormone levels, to initiate plant regeneration. Following somatic embryo maturation (2-4 weeks), well-developed somatic embryos are transferred to medium for germination and transferred to the lighted culture room. Approximately 7-10 days later, developing plantlets are transferred to medium in tubes for 7-10 days until plantlets are well established. Plants are then transferred to inserts in flats (equivalent to 2.5″ pot) containing potting soil and grown for 1 week in a growth chamber, subsequently grown an additional 1-2 weeks in the greenhouse, then transferred to classic 600 pots (1.6 gallon) and grown to maturity. Plants are monitored for expression of the gene of interest.

Example 9

[0220] Transformation of Callus and Regeneration of Corn Plants—Particle Gun.

[0221] Type II Callus Isolation and Maintenance.

[0222] After 10-21 days, type II callus is initiated from the scutellum and appears as a friable, embryogenic outgrowth of rapidly dividing cells. Callus is subcultured every 5-10 days and maintained on N6 medium supplemented with 1 mg/L 2,4-D (CM). These cultures are used in transformation experiments from 5 to 12 weeks after initiation.

[0223] Preparation of Callus for Transformation.

[0224] Proembryogenic type II callus is transferred to #4 Whatman filter paper on CM media. The CM plates with callus is wrapped with parafilm and incubated in the dark Conviron growth chamber (45% humidity, 27-28° C.) for two days before bombardment. Prior to bombardment, the osmotic plates are left partially ajar for thirty minutes in the laminar flow hood to allow moisture on the tissue to dissipate.

[0225] Gold Particle Preparation

[0226] Sixty mg of 0.6 micron gold is weighed out in a siliconized eppendorf tube (Axgen Microtubes—1.7 ml clear tube). The tube is left stationary for 15 minutes and spun down. The pellet is rinsed with sterile water three more times. Subsequently, one ml of sterile water is added to the gold pellet and vortexed for 10 minutes. The gold particles are divided into 50 ul aliquots.

[0227] DNA/Gold Preparation

[0228] Fifty μL of 0.6 micron gold in sterile dd H2O. A 2:1 molar ratio of trait gene:bar gene (usually ˜5-10 ug in total DNA) is added and vortexed. Subsequently, fifty μL of 2.5 M CaCl2 is added quickly into the suspension and vortexed followed by the addition of 20 μL of 0.1 M spermidine and vortexed and spun down. The pellet is rinsed 3× in 100% ethanol. The pellet is gently resuspended by tapping the side of the eppendorf tube several times. The DNA prep is stored in the 20° C. freezer.

[0229] Loading of the Macrocarrier

[0230] The DNA/gold prep is thawed and sonicated (2 strokes) in the Branson 200 Ultrasonic cleaner prior to the addition to macrocarriers. The suspension is mixed well by pipetting in and out. Immediately, 6 μl of DNA/gold suspension is dispensed quickly to the center of each macrocarrier. Once the DNA prep is dried onto the macrocarrier, the PDS-100/He Gun is used to bombard the maize callus cells with the DNA-coated gold particles.

[0231] Particle Gun Parameters.

[0232] Plates containing callus are the bombarded with the PDS-1000/He Gun using the following parameters: 1) DNA precipitated onto 0.6 μM Gold particles; 2) 8 cm distance from stopping screen; 3) 27-29 inches Hg vacuum; 4) 1050-1100 PSI He pressure.

[0233] Selection of Transgenic Callus Lines.

[0234] After 3-4 days of incubation in the dark chamber the callus is transferred (3-4 mm clumps) onto media containing 3-5 ppm bialaphos (SM3 or SM5). The SM plates are incubated in the dark at 27° C. for ˜7-14 days. Thereafter, all callus is transferred onto SM (5 ppm bialaphos) keeping track of unique lines as above. Each clump may be split into several pieces at this transfer.

[0235] Regeneration of Transgenic Maize Plants.

[0236] Callus events are isolated onto fresh SM medium, sampled for PCR (polymerase chain reaction) and placed on first-stage regeneration media (RM31). After 10-14 days, the proembryogenic callus are transferred onto fresh RM3 plates and placed in the light chamber at 26° C. Plantlets approximately 2-3 cm are removed and transfer to RM4 media tubs. After 1-2 weeks plants from RM4 are potted to a maximum of two plantlets per pot. The pots are then placed in the Conviron growth chamber (photolight=20 hours, humidity=65%, temperature=24° C.) and watered with Roots2 solution. Plants (˜20 cm tall) are tested for expression of the bar gene by performing a 2% basta swipe test.

Example 10

[0237] Analysis of Fatty Acid Content and Composition by Gas Chromatography (GC)

[0238] Fatty acid (FA) determination was done from a total of 300-400 mg of tissue lyophilized for 24 hours. The tissue was then ground using a FastPrep mill (Biol101) at 4.5 speed and 20 seconds in the presence of 0.5 ml of 2.5% Sulfuric Acid+97.5% Methanol and Heptadecanoic acid (17:0, stock 10 mg/ml in Tuloene) as an external standard. Thereafter, another 0.5 ml 2.5% Sulfuric Acid +97.5% Methanol was used to wash each tube and incubate in 95° C. for 1 hour for transesterification. The tubes were removed from the water bath and allowed to cool down to RT. FAs were extracted in one volume of heptane:H2O (1:1) and cleared by centrifugation. The supernatant (50 ul) containing the fatty acid methyl esters were loaded into a Hewlett Packard 6890 gas chromatograph fitted with a 30 m×0.32 mm Omegawax column and the separated peaks were analyzed and characterized.

Example 11

[0239] Lec 1 Over-Expression Leads to Altered Fatty Acid Accumulation in Maize Somatic Embryos

[0240] The ubiquitin promoter (Christensen et al (1992) Plant Mol Biol 18:675-89) was used to drive Hap3/Lec1 expression (outlined in Example 7) in maize embryogenic callus to test what phenotype would arise from over-expression of Lec1 in somatic embryos. Transformation of the construct into maize embryogenic callus and generation of somatic embryos is outlined in Example 9.

[0241] More than ten different events were analysed by GC for fatty acid content/composition and compared to controls transformed with the selectable marker (BAR gene) plasmid alone. A pool of three embryos each from XX different events showed that the somatic embryos overexpressing Lec1 contain elevated fatty acid content (average 119% increase over control) with no significant alteration in fatty acid composition when compared to the control somatic embryos (FIG. 1).

Example 12

[0242] Nuclear Magnetic Resonance (NMR) ANALYSIS

[0243] Seed are imbibed in distilled water for 12-24 hours at 4° C. The embryo is dissected away and stored in a 48 well plate. The samples are lyophilized over-night in a Virtis 24×48 lyophilizer. The NMR (Process Control Technologies—PCT (Ft. Collins, Colo.) is set up as per the manufacturer's instructions. The NMR is calibrated using a series of 5 mm NMR tubes containing precisely measured amounts of corn oil (Mazola). The calibration standards are 3, 6, 9, 12, 15, 18, 21, 27, 33, and 40 mg of oil.

Example 13

[0244] Lec 1 Over-Expression Leads to Altered Oil Accumulation in Maize Kernels

[0245] The Hap3/Lec1 expression construct with the oleosin promoter (outlined in Example 7) was introduced into maize to test what phenotype would arise from seed specific over-expression. Transformation of the construct into maize was accomplished using Agrobacterium tumefaciens as follows.

[0246] Freshly isolated immature embryos of maize, about 10 days after pollination (DAP), are incubated with the Agrobacterium. The preferred genotype for transformation is the highly transformable genotype Hi-II (Armstrong, C. L., 1991, Development and Availability of Germplasm with High Type II Culture Formation Response, Maize Genetics Cooperation Newsletter, 65:92-93). An F1 hybrid created by crossing with an Hi-II with an elite inbred may also be used. After Agrobacterium treatment of immature embryos, the embryos are cultured on medium containing toxic levels of herbicide. Only those cells which receive the herbicide-resistance gene, and the linked gene(s), grow on selective medium. Transgenic events so selected are propagated and regenerated to whole plants, produce seed, and transmit transgenes to progeny.

[0247] The engineered Agrobacterium tumefaciens LBA4404 is constructed as per U.S. Pat. No. 5,591,616 to contain the linked gene(s) and the selectable marker gene. Typically either BAR (D'Halluin et al (1992) Methods Enzymol. 216:415-426) or PAT (Wohileben et al (1988) Gene 70:25-37) may be used.

[0248] To use the engineered vector in plant transformation, a master plate of single bacterial colonies is first prepared by inoculating the bacteria on minimal AB medium and then incubating the bacteria plate inverted at 28° C. in darkness for about 3 days. A working plate is then prepared by selecting a single colony from the plate of minimal A medium and streaking it across a plate of YP medium. The YP-medium bacterial plate is then incubated inverted at 28° C. in darkness for 1-2 days.

[0249] Agrobacterium for plant transfection and co-cultivation is prepared 1 day prior to transformation. Into 30 ml of minimal A medium in a flask is placed 50 μg/ml spectinomycin (or appropriate bacterial antibiotic depending on marker in co-integrate), 100 μM acetosyringone, and about a ⅛ loopful of Agrobacterium from a 1 to 2-day-old working plate. The Agrobacterium is then grown at 28° C. at 200 rpm in darkness overnight (about 14 hours). In mid-log phase, the Agrobacterium is harvested and resuspended at 3 to 5×108 CFU/ml in 561 Q medium+100 μM acetosyringone using standard microbial techniques and standard curves.

[0250] Immature Embryo Preparation

[0251] Nine to ten days after controlled pollination of a corn plant, developing immature embryos are opaque and 1-1.5 mm long and are the appropriate size for Agro-infection. The husked ears are sterilized in 50% commercial bleach and 1 drop Tween for 30 minutes, and then rinsed twice with sterile water. The immature embryos are aseptically removed from the caryopsis and placed into 2 ml of sterile holding solution comprising of 561Q+100 μM acetosyringone.

[0252] Agrobacterium Infection and Co-cultivation of Embryos

[0253] Holding solution is decanted from excised immature embryos and replaced with prepared Agrobacterium. Following gentle mixing and incubation for about 5 minutes, the Agrobacterium is decanted from the immature embryos. Immature embryos are then moved to a plate of 562P medium, scutellum surface upwards, and incubated at 20° C. for 3 days in darkness followed by incubation at 28° C. for 3 days in darkness on medium 562P+100 mg/ml carbenecillin (see U.S. Pat. No. 5,981,840).

[0254] Selection of Transgenic Events

[0255] Following incubation, the immature embryos are transferred to 563O medium for selection of events. The transforming DNA possesses a herbicide-resistance gene, in this example the PAT gene, which confers resistance to bialaphos. At 10- to 14-day intervals, embryos are transferred to 5630 medium. Actively growing putative transgenic embryogenic tissue is visible in 6-8 weeks.

[0256] Regeneration of T0 Plants

[0257] Transgenic embryogenic tissue is transferred to 288W medium and incubated at 28° C. in darkness until somatic embryos matured, or about 10 to 18 days. Individual matured somatic embryos with well-defined scutellum and coleoptile are transferred to 272 embryo germination medium and incubated at 28° C. in the light. After shoots and roots emerge, individual plants are potted in soil and hardened-off using typical horticultural methods.

[0258] Confirmation of Transformation

[0259] Putative transgenic events are subjected to analysis to confirm their transgenic nature. Events are tested for the presence of Lec1 by PCR amplification. Additionally, T0 plants are painted with bialaphos herbicide. The subsequent lack of a herbicide-injury lesion indicates the presence and action of the herbicide resistance gene. The plants are monitored and scored for altered Lec1 expression and/or phenotype such as increased organic sulfur compounds.

[0260] Media Recipes

[0261] Medium 561 Q contains the following ingredients: 950.000 ml of D-I Water, Filtered; 4.000 g of Chu (N6) Basal Salts (Sigma C-1416); 1.000 ml of Eriksson's Vitamin Mix (1000+Sigma-1511); 1.250 ml of Thiamine.HCL.4 mg/ml; 3.000 ml of 2, 4-D 0.5 mg/ml (No. 2A); 0.690 g of L-proline; 68.500 g of Sucrose; and 36.000 g of Glucose. Directions are: dissolve ingredients in polished deionized water in sequence; adjust pH to 5.2 w/KOH; Q.S. to volume with polished deionized water after adjusting pH; and filter sterilize (do not autoclave).

[0262] Medium 562 P contains the following ingredients: 950.000 ml of D-I Water, Filtered; 4.000 g of Chu (N6) Basal Salts (Sigma C-1416); 1.000 ml of Eriksson's Vitamin Mix (1000×Sigma-1511); 1.250 ml of Thiamine.HCL.4 mg/ml; 4.000 ml of 2, 4-D 0.5 mg/ml; 0.690 g of L-proline; 30.000 g of Sucrose; 3.000 g of Gelrite, which is added after Q.S. to volume; 0.425 ml of Silver Nitrate 2 mg/ml #; and 1.000 ml of Aceto Syringone 100 mM #. Directions are: dissolve ingredients in polished deionized water in sequence; adjust pH to 5.8 w/KOH; Q.S. to volume with polished deionized water after adjusting pH; and sterilize and cool to 60° C. Ingredients designated with a # are added after sterilizing and cooling to temperature.

[0263] Medium 563 O contains the following ingredients: 950.000 ml of D-I Water, Filtered; 4.000 g of Chu (N6) Basal Salts (Sigma C-1416); 1.000 ml of Eriksson's Vitamin Mix (1000×Sigma-1511); 1.250 ml of Thiamine.HCL.4 mg/ml; 30.000 g of Sucrose; 3.000 ml of 2, 4-D 0.5 mg/ml (No. 2A); 0.690 g of L-proline; 0.500 g of Mes Buffer; 8.000 g of Agar (Sigma A-7049, Purified), which is added after Q.S. to volume; 0.425 ml of Silver Nitrate 2 mg/ml #; 3.000 ml of Bialaphos 1 mg/ml #; and 2.000 ml of Agribio Carbenicillin 50 mg/ml #. Directions are: dissolve ingredients in polished deionized water in sequence; adjust to pH 5.8 w/koh; Q.S. to volume with polished deionized water after adjusting pH; sterilize and cool to 60° C. Ingredients designated with a # are added after sterilizing and cooling to temperature.

[0264] Medium 288 W contains the following ingredients: 950.000 ml of D-I H2O; 4.300 g of MS Salts; 0.100 g of Myo-Inositol; 5.000 ml of MS Vitamins Stock Solution (No. 36J); 1.000 ml of Zeatin.5 mg/ml; 60.000 g of Sucrose; 8.000 g of Agar (Sigma A-7049, Purified), which is added after Q.S. to volume; 2.000 ml of IAA 0.5 mg/ml #; 1.000 ml of 0.1 Mm ABA #; 3.000 ml of Bialaphos 1 mg/ml #; and 2.000 ml of Agribio Carbenicillin 50 mg/ml #. Directions are: dissolve ingredients in polished deionized water in sequence; adjust to pH 5.6; Q.S. to volume with polished deionized water after adjusting pH; sterilize and cool to 60° C. Add 3.5 g/L of Gelrite for cell biology. Ingredients designated with a # are added after sterilizing and cooling to temperature.

[0265] Medium 272 contains the following ingredients: 950.000 ml of deionized water; 4.300 g of MS Salts; 0.100 g of Myo-Inositol; 5.000 of MS Vitamins Stock Solution; 40.000 g of Sucrose; and 1.500 g of Gelrite, which is added after Q.S. to volume. Directions are: dissolve ingredients in polished deionized water in sequence; adjust to pH 5.6; Q.S. to volume with polished deionized water after adjusting pH; and sterilize and cool to 60° C.

[0266] Medium minimal A contains the following ingredients: 950.000 ml of deionized water; 10.500 g of potassium phosphate dibasic K2HPO4; 4.500 g of potassium phosphate monobasic KH2PO4; 1.000 g of ammonium sulfate; 0.500 g of sodium citrate dihydrate; 10.000 ml of sucrose 20% solution #; and 1.000 ml of 1 M magnesium sulfate #. Directions are: dissolve ingredients in polished deionized water in sequence; Q.S. to volume with deionized water; sterilize and cool to 60° C. Ingredients designated with a # are added after sterilizing and cooling to temperature.

[0267] Medium minimal AB contains the following ingredients: 850.000 ml of deionized water; 50.000 ml of stock solution 800A; 9 g of Phytagar which is added after Q.S. to volume; 50.000 ml of stock solution 800B #; 5.000 g of glucose #; and 2.000 ml of spectinomycin 50/mg/ml stock #. Directions are: dissolve ingredients in polished deionized water in sequence; Q.S. to volume with polished deionized water less 100 ml per liter; sterilize and cool to 60° C. Ingredients designated with a # are added after sterilizing and cooling to temperature. Stock solution 800A contains the following ingredients: 950.000 ml of deionized water; 60.000 g of potassium phosphate dibasic K2HPO4; and 20.000 g of sodium phos. monobasic, hydrous. Directions are: dissolve ingredients in polished deionized water in sequence; adjust pH to 7.0 with potassium hydroxide; Q.S. to volume with polished deionized water after adjusting pH; and sterilize and cool to 60° C. Stock solution 800B contains the following ingredients: 950.000 ml of deionized water; 20.000 g of ammonium chloride; 6.000 g of magnesium sulfate 7-H2O, MgSO4, 7 H2O; 3.000 g of potassium chloride; 0.200 g of calcium chloride (anhydrate); and 0.050 g of ferrous sulfate 7-hydrate. Directions are: dissolve ingredients in polished deionized water in sequence; Q.S. to volume with polished deionized water; and sterilize and cool to 60° C.

[0268] Medium minimal YP contains the following ingredients: 950.000 ml of deionized water; 5.000 g of yeast extract (Difco); 10.000 g of peptone (Difco); 5.000 g of sodium chloride; 15.000 g of bacto-agar, which is added after Q.S. to volume; and 1.000 ml of spectinomycin 50 mg/ml stock #. Directions are: dissolve ingredients in polished deionized water in sequence; adjust pH to 6.8 with potassium hydroxide; Q.S. to volume with polished deionized water after adjusting pH; sterilize and cool to 60° C. Ingredients designated with a # are added after sterilizing and cooling to temperature.

[0269] More than twenty events producing segregating T1 seed were analyzed by NMR for embryo oil content (see Example 12). Six to twelve embryos analyzed for each of five different events showed that some embryos within each event contained elevated oil content. These results are shown in FIG. 2. The same embryos from these five events were analyzed by PCR to determine the presence or absence of the Lec1 construct. Embryos with high oil are always found to contain the Lec1 construct (darkly shaded bars), whereas embryos with normal levels of oil were typically found not to contain the Lec1 construct (cross-hatched bars). These data demonstrate the presence of the Lec1 gene does lead to increased oil in the embryo. It is believed that embryos containing sharply higher levels of oil were homozygous for the Lec1 construct, as these events were segregating 1:2:1. For these events, the oil concentration in the embryos containing the Lec1 construct greatly surpassed any increase previously achieved through enzymatic modification of the fatty acid biosynthetic pathway, with some embryos containing an average increase of 56% in embryo oil content (FIG. 2, Event 277267). Plants derived from seed that contained high oil exhibit some phenotypic changes in growth and development. There is an accumulation of additional leaves during early growth and development phase, and strong leaf curling throughout plant growth and development.

Example 14

[0270] Additional Promoters Coupled to Lec1 Also Result in Altered Maize Kernel Oil Accumulation

[0271] Other types of seed-specific promoters, the lipid transfer protein promoter and the gamma zein promoter, were also tested for their ability to alter oil accumulation in maize kernels when expressing Lec1. Transformation and analysis of these constructs was essentially the same as protocols outlined in Example 13. More than twenty events producing segregating T1 seed are analyzed by NMR for embryo oil content (see Example 12). Six to twelve embryos were analyzed for each event. Events containing embryos with high oil content were analyzed further. The same embryos from these events are analyzed by PCR to determine the presence or absence of the Lec1 construct. As with the oleosin promoter containing construct, all embryos with high oil contents are found to contain the Lec1 construct, whereas embryos with lower or normal oil contents are typically found not to contain the Lec1 construct. Like the events containing Lec1 and the oleosin promoter, the oil concentration in the embryo for these events also greatly surpass any increase previously achieved through enzymatic modification, with some embryos containing an average increase of more than 50% in embryo oil content.

[0272] Surprisingly, plants derived from seed containing high oil using this construct do not show the abnormal phenotype found for plants expressing Lec1 under the control of the oleosin promoter. It is believed that these data demonstrate that high oil can be achieved in the embryo without negative agronomic effects when the appropriate expression is employed.

Alteration of oil traits in plants

Information

Publication Number

Date Filed

Date Published

Inventors

CPC

US Classifications

International Classifications

Abstract

Description

Claims

Parent Case Info

Provisional Applications (1)